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Abstract 
Single-molecule experiments have been designed and carried out for investigating the 
mechanical and biological properties of proteins, and molecular interactions at a single 
molecular level [1, 2]. Since the first single-molecule technique, patch clamp, was 
developed in the 1970s [3], a variety of other techniques and instruments have been 
developed, including atomic force microscopy (AFM) [4–8], optical tweezers [9–19], 
magnetic tweezers [20–27], and biomembrane force probes (BFP) [28–30]. These 
optimized instruments are able to achieve high spatial resolution (nanometers), 
temporal resolution (microseconds), and force sensitivity (piconewtons). Furthermore, 
they allow us to carry out the single-molecule experiments in a force-clamp mode or 
force-ramp mode. In order to quantify the biological properties of the molecule, we can 
consider the molecule as an elastic chain and apply the worm-like chain (WLC) model 
[31, 32]. To characterize the mechanical properties of proteins or interactions, the Bell–
Evans model [33] and Dudko model [34] are available, both of which are derived from 
Kramers theory [35]. 
This thesis focuses on three projects of single-molecule force experiments using 
optical tweezers and AFM. In the first project, we performed single-molecule force 
experiments on the platelet mechanosensor glycoprotein (GP) Ib-IX complex. We 
successfully identified a juxtamembrane mechanosensory domain (MSD) in GPIb-IX, 
and further proposed a model of GPIb-IX mechanosensing (i.e., the “trigger model”). 
In this model, the force-induced unfolding of MSD is the step by which GPIb-IX 
converts a mechanical signal into a change of the protein conformation, a type of signal 
that could be recognized and transduced further. This has significant implications for 
the pathogenesis and treatment of related blood diseases. 
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In the second project, we developed a novel SpyTag system for single-molecule 
experiments, inspired by the recent discovery of the SpyTag/SpyCatcher covalent 
bonds [36]. In a single-molecule experimental system, linking methods are usually used 
to capture, hold, and further apply an external force on the molecule. The traditional 
methods have many disadvantages, such as low mechanical stability and strength, or 
requiring the sample purification and reduction reaction. In our newly developed 
SpyTag system, we can perform the single-molecule pulling experiments efficiently 
since the SpyTag/SpyCatcher covalent bonds have high mechanical stability and 
mechanical strength. The minimal difference in the lifetimes of the C-terminal 
SpyTag/SpyCatcher and N-terminal SpyTag/SpyCatcher, indicates that we can fuse 
either terminal of the SpyTag to some other proteins without sacrificing the covalent 
bonds stability. This property makes the single-molecule experiments simpler. 
Furthermore, the new system simplifies the single-molecule experiments by eliminating 
the sample purification step, as well as providing a new approach to investigate 
complexed proteins, such as the integrin α4β7. In addition, the novel system does not 
involve any protein reduction procedure. This property makes the system promising for 
measuring the domain-domain interactions within a protein, such as the von Willebrand 
factor (VWF), where traditional methods are not practical since the sample reduction 
step would also break the abundant inner disulfide bonds of VWF.  
Finally, we aimed to investigate the domain-domain interactions within VWF, as 
well as the influence of the clotting factor VIII (FVIII) in VWF folding/unfolding, using 
the novel SpyTag system. Our experimental results showed that, there existed 
differences in the force spectrum of pulling VWF fragments, D’D3A1 or D’D3A1A2, 
in the absence and presence of 5 nM FVIII. We referred that FVIII binding to VWF 
altered the force-induced unfolding of D’D3A1A2 fragment, and possibly changed the 
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normal A2 unfolding pathway where no FVIII existed. However, more unfolding events 
are still needed to clearly reveal the function of FVIII as well as the interaction between 
FVIII and D’D3A1 or D’D3A1A2. Meanwhile, we intended to investigate the influence 
of FVIII on the A2 unfolding pathways, by performing single-molecule experiments on 
the A2 protein, with or without FVIII. Besides, we need to use D’D3 generated by 
mammalian cells instead of bacterial cells, to repeat the single-molecule experiments.  
These projects have significant implications for the pathogenesis and treatment of 
related blood diseases. 
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Chapter 1: Introduction 
1.1 Hemostasis and Haemostasis 
Hemostasis or haemostasis is a natural physiological process that causes bleeding 
to stop and prevent blood loss at the site of injury. The process includes two main 
components—the primary hemostasis and the secondary hemostasis. 
The primary hemostasis includes two steps, vasoconstriction (vascular spasm) and 
platelet plug formation. Vasoconstriction is the first response of blood vessels to blood 
vessel damage, which is controlled by vascular smooth muscle cells. At the site of 
damage, the blood vessels constrict to reduce the volume of blood flow passing through 
and limit the loss of blood, which is effective in small blood vessels [37, 38]. In the 
platelet plug formation step, platelets first adhere to subendothelial matrix proteins (e.g. 
collagen) through the interactions of collagen with the platelet surface receptor 
glycoprotein (GP) VI and integrin α2β1 (the platelet GPIa/IIa complex), and of collagen 
with the platelet GPIb-IX-V complex via von Willebrand factor (VWF) (Figure 1.1A) 
[39, 40]. Platelet activation is associated with a change in platelet shape, secretion of 
platelet agonists, such as thromboxane A2 (TXA2) and adenosine diphosphate (ADP), 
and intracellular signaling which leads to further integrin αIIbβ3 (GPIIb/IIIa) activation. 
A platelet plug is finally formed by aggregated platelets via fibrinogen bridges (Figure 
1.1B). In healthy blood vessels, the endothelial cells produce and secrete coagulation 
and aggregation inhibitors, such as nitric oxide and prostacyclin, instead of VWF, to 
prevent blood clotting and platelet aggregation. 
The secondary hemostasis consists of a cascade of blood coagulation or clotting, 
and converts the liquid blood into a semi-solid gel. In this process, the main role is 
played by an enzyme, called thrombin, which converts inactive soluble fibrinogen into 
insoluble fibrin fibers, thus forming an interlocking meshwork of fibers and a 
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framework to trap erythrocytes for the clot. The conversion of inactive prothrombin to 
thrombin is initiated by two pathways: (1) the intrinsic pathway or the contact activation; 
and (2) the extrinsic pathway or the tissue factor (TF) pathway. There are at least twelve 
factors, generally indicated by Roman numerals, involved in the series of reactions, and 
these coagulation factors circulate as inactive zymogens in blood. Most factors are 
serine proteases (enzymes) and act by cleaving downstream proteins. However, factor 
VIII (FVIII) and factor V (FV) are glycoproteins, and factor XIII (FXIII) is a 
transglutaminase [41]. 
 
Figure 1.1 Platelet adhesion and aggregation. (A) Platelet adhesion. In the platelet plug 
formation step, platelets first adhere to subendothelial matrix proteins (e.g. collagen) 
through the interactions of collagen with the platelet surface receptor glycoprotein (GP) 
VI and integrin α2β1 (the platelet GPIa/IIa complex), and of collagen with the platelet 
GPIb-IX-V complex via VWF. (B) Platelet aggregation through the binding of 
activated platelets. Platelet activation is associated with a change in platelet shape, 
secretion of platelet agonists, such as thromboxane A2 (TXA2) and adenosine 
diphosphate (ADP), and intracellular signaling which leads to further integrin αIIbβ3 
(GPIIb/IIIa) activation. A platelet plug is finally formed by aggregated platelets via 
fibrinogen bridges. Figures are captured from https://youtu.be/0pnpoEy0eYE, 
produced by Mechanisms in Medicine Inc. 
 
1.1.1 Bleeding Disorders 
Bleeding disorders are a group of conditions where the blood cannot clot normally 
when needed. These diseases can be inherited or acquired, while most of them are 
genetically inherited, such as the most well-known hemophilia. As described before, 
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the process of hemostasis requires the platelets and as many as twenty different plasma 
proteins to function properly, including von Willebrand factor (VWF) and other blood 
clotting factors. There are many different classification methods for characterizing 
different types of bleeding disorders [42–45], among which hemophilia, von 
Willebrand disease (VWD), and factor XI (FXI) deficiency are the most common with 
general population prevalence rates of between 1 and 0.001% [46, 47]. 
Hemophilia or haemophilia contains three types, each of which is related to 
deficiency of one type of clotting factor. Hemophilia A and hemophilia B result from 
deficiencies in factor VIII (FVIII) and factor IX (FIX), respectively. The two types of 
hemophilia are recessive sex-linked, X chromosome disorders, so they are more likely 
to occur in males than females. According to the most recent survey [48], approximately 
62% of bleeding disorders are hemophilia, and ~80% of those are of type A and ~16% 
are of type B. There are mild, moderate and severe forms of both types of hemophilia, 
which reflect the level of active FVIII or FIX in the plasma. Hemophilia C is an 
autosomal genetic disorder resulting from the deficiency of FXI, and not completely 
recessive. 
Von Willebrand disease (VWD) is an inherited condition resulting from the 
deficiency or defect in von Willebrand factor (VWF), where the mode of inheritance is 
autosomal. VWD is the most common inherited bleeding disorder of humans. VWF 
functions in the primary hemostasis, and also carries another clotting protein FVIII. 
Deficiency in VWF causes defective platelet adhesion and a secondary deficiency in 
FVIII. The outcome is that VWF deficiency can cause bleeding that appears similar to 
that caused by platelet dysfunction or hemophilia, though it is usually milder than 
hemophilia. VWD is classified into three major types (i.e., Types 1, 2, and 3), based on 
the levels of VWF and FVIII’s activity in the blood. Type 1 VWD, the mildest and most 
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common form, is inherited as an autosomal dominant trait. Type 2 VWD, similar to 
Type 1 VWD, is subdivided further depending on whether the dysfunctional protein 
has decreased or paradoxically increased function in the binding to platelets. Type 3 
VWD, the most severe and least common form, which is characterized by recessive 
inheritance and virtual absence of VWF. For treatment of serious cases, patients may 
need to take the drugs that can help to increase the level of VWF in the blood or with 
infusions of blood factor concentrates. 
 
1.1.2 Von Willebrand Factor (VWF) 
As shown before, in human hemostasis or the coagulation process, there are 
complicated interactions between platelets and proteins in the plasma. In primary 
hemostasis, platelet adhesion to exposed collagen on subendothelial matrix is mediated 
by the von Willebrand factor (VWF) bridge. Its structure helps to give it specific 
biochemical and immunologic properties, and allows for unique and essential 
physiologic functions [49]. Defects in VWF or other related receptors will cause 
bleeding diseases, such as hemophilia and von Willebrand diseases. 
 The mechanical shear force generated by blood flow in the vasculature is a critical 
factor that mediates physiologic hemostasis and pathologic thrombosis. Platelet 
adhesion to collagen is mediated by VWF multimers (shown in Figure 1.2). The VWF 
multimers act as an intermediary bridge between collagen fibrils on damaged blood 
vessel walls and platelets in blood. Platelet adhesion and aggregation, which is induced 
by the enhanced shear stress, requires the existence of VWF and its platelet surface 
receptor glycoprotein (GP) Ib-IX and integrin αIIbβ3 (GPIIb/IIIa) [50, 51]. It has also 
been shown that both VWF and GPIb-IX complex are capable of sensing and reacting 
to tensile forces [52, 53]. 
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Figure 1.2 Schematic of multimeric VWF mediating platelet adhesion to collagen. 
Mature VWF monomer subunits (2050 amino acids) form VWF dimers and further 
multimers with variable lengths through disulfide bonds. During the blood clotting 
process, the VWF multimers are immobilized through the A3 domain on the collagen 
fibrils existing on the sub-endothelium of blood vessel wall, while its A1 domain binds 
to the platelet surface receptor GPIb-IX. 
Von Willebrand factor (VWF) is an ultra-large, multimeric vascular protein, which 
plays an essential role in capturing platelets onto the damaged blood vessel wall, 
allowing the initiation of blood clotting. VWF is an adhesive glycoprotein existing in 
different types of cells, such as platelets, endothelial cells and megacariocites. It is 
synthesized as a large mature VWF monomer subunit (2050 amino acids), and these 
subunits are capable of forming dimers and further multimers with variable lengths 
through disulfide bonds, as illustrated in Figure 1.2 and Figure 1.3. VWF concatamers 
in plasma can contain up to 40 to 200 monomers, corresponding to molecular weights 
of up to 4000 to 10000 kDa, and can be extended to lengths of up to 3 to 15 μm [54, 
55]. 
As shown in Figure 1.3, VWF monomer is a mosaic protein, consisting of several 
domains. Each domain contributes to some function(s). VWF is secreted to plasma 
though an initially narrow secretion pore, in the form of long tubules characteristic of 
Weibel-Palade bodies (WPB), i.e., a concatamer. 
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Figure 1.3 Primary structure and domain organization of VWF monomer. VWF 
domains are arranged as the figure shows. Cysteines are connected for chemically 
determined disulfide bonds [56, 57]. VWF acts as a carrier for factor VIII (FVIII) in 
blood circulation. FVIII interacts with D’D3 domain. Platelet binding to VWF is 
through the binding of VWF A1 domain to the Ibα chain of platelet surface receptor 
glycoprotein (GP) Ib-IX [58]. The metalloprotease ADAMTS13 is only able to cleave 
the unfolded A2 domain to produce smaller VWF multimers, to facilitate VWF release 
into bloodstream, and promote hemostasis [53, 55, 59]. The binding of VWF to collagen 
is through its A2 domain. 
In stasis, the concatamer forms an irregularly coiled, compact shape, due to self-
association between VWF monomers [60, 61]. When the blood shear flow increases, 
VWF extends, and is stretched to from a chain-like shape when the shear rate is above 
a critical threshold ~5000 s-1 [55, 62–65]. The elongated VWF exposes its A1-A2-A3 
domains, which is correlated with activation of VWF-mediated platelet aggregation, 
platelet binding and rolling on VWF substrates, and binding of VWF to collagen and 
VWF substrates [66]. VWF is capable of sensing and responding to tensile forces, 
which induces the unfolding of the A2 domain. The metalloprotease ADAMTS13 is 
only able to cleave the unfolded A2 domain to produce smaller VWF multimers, help 
to facilitate VWF release into bloodstream, and promote hemostasis [53, 55, 59]. 
Platelet binding to VWF is through the binding of VWF A1 domain to the Ibα chain of 
platelet surface receptor glycoprotein (GP) Ib-IX [58]. VWF binding to collagen is 
achieved mainly by A3 binding to collagen III and A1 binding to collagen VI [55, 67–
70]. 
The crystal structures of VWF A1 domain and A2 domain are shown in Figure 1.4. 
The A1 domain contains N- and C-terminal arms that wrap across the domain’s lower 
surface (Figure 1.4A). VWF A1 does not contain a metal ion-dependent adhesion site 
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motif [71]. The Ibα chain of platelet surface receptor GPIb-IX possibly binds to the 
front and upper surfaces of A1. The VWF A2 domain contains a loop in place of the α4 
helix, and a cis-proline (Figure 1.4B) [72]. The Tyr-Met cleavage site is buried in the 
poorly packed β4-strand in the central hydrophobic core. A2 has a C-terminal α6-helix, 
which is linked to the Tyr structurally. 2 Cysteine residues on the α6-helix are linked 
by an unusual vicinal disulfide bond. 
 
Figure 1.4 Structure of VWF A1 domain and A2 domain. (A) VWF A1 domain has a 
highly conserved set of hydrogen bonds external to the long-range disulfide (not drawn 
here) seen in all crystal structures. (B) VWF A2 domain has a C-terminal, vicinal 
disulfide bond and lacks of α4 loop [72–75]. 
 
1.1.3 Glycoprotein (GP) Ib-IX Complex 
The glycoprotein (GP) Ib-IX-V complex, expressed exclusively on plasma platelets 
and megakaryocytes, is the platelet receptor for VWF and many other molecules 
involved in hemostasis and thrombosis [76, 77]. GPIb-IX-V complex contains GPIb-
IX and GPV. However, the association between them is relatively weak [78]. The GPIb-
IX complex consists of GPIbα, GPIbβ, and GPIX subunits in a 1:2:1 stoichiometry [79, 
80]. GPIbα contains, starting from the N-terminus, a leucine-rich repeat (LRR) domain, 
a highly glycosylated macroglycopeptide region, a stalk region of about 60 residues, a 
pair of cysteine residues that connect to GPIbβ via disulfide bonds, a single-span 
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transmembrane helix, and a relatively short cytoplasmic domain that is connected to the 
cytoskeleton through filamin A [81]. The complex is capable of sensing the blood flow 
through its binding to VWF A1 domain and further transmitting a signal into the platelet 
[52]. However, the mechanism of this signaling was not clarified for a long period. The 
organization of GPIb-IX complex is shown in Figure 1.5A. The VWF-A1–GPIbα 
complex forms a super β-sheet at the interface between the A1 β3 and GPIbα β14 
strands (Figure 1.5B). 
 
Figure 1.5 Organization of GPIb-IX complex. (A) The GPIb-IX complex consists of 
GPIbα, GPIbβ, and GPIX subunits in a 1:2:1 stoichiometry [79, 80]. GPIbα contains, 
starting from the N-terminus, a leucine-rich repeat (LRR) domain, a highly glycosylated 
macroglycopeptide region, a stalk region of about 60 residues, a pair of cysteine 
residues that connect to GPIbβ via disulfide bonds, a single-span transmembrane helix, 
and a relatively short cytoplasmic domain that is connected to the cytoskeleton through 
filamin A [81]. (B) The VWF-A1–GPIbα complex forms a super β-sheet at the interface 
between the A1 β3 and GPIbα β14 strands. 
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1.1.4 Human Factor VIII (FVIII) / Antihemophilic Factor 
Human factor VIII (FVIII) or the antihemophilic factor is one of the most important 
serum proteins in hemostasis and coagulation. The mature FVIII is synthesized as a 
single polypeptide chain of 2332 amino acid residues (~280 kDa) by various tissues, 
including the liver, kidney, and spleen [82–84]. It has the domain structure A1-A2-B-
A3-C1-C2 [82, 85], as shown in Figure 1.6. The A1-A2 domains are present in the 
heavy chain (HC) with a molecular weight varying between 90 kDa and 200 kDa [84], 
while the domains A3-C1-C2 form the light chain (LC) with a molecular weight of 76 
kDa [86]. A region of the C2 domain contains a membrane binding site of FVIII and 
the site of interaction with VWF [87]. FVIII circulates as a series of noncovalent 
heterodimers with VWF, produced by proteolytic cleavage at the B-A3 junction or 
within the B domain [88]. At the site of a vascular injury, it nucleates the assembly of 
a membrane-bound protease complex on the surface of activated platelets. During the 
blood coagulation process, FVIII acts as a cofactor to the serine protease factor IXa 
(FIXa). FVIII is released after the peptide containing the VWF-binding site is removed 
by proteolysis near the N-terminus of LC by traces of thrombin. Further proteolysis 
between the A1 and A2 domains results in generation of FVIIIa, the active 
heterotrimeric cofactor. Upon proteolytic activation by either FXa or thrombin, FVIIIa 
dissociates from VWF, binds to the FIXa serine protease, and directs the localization 
of the resulting complex to the membrane surface of activated platelets via an 
interaction with its C-terminal C2 domain. The membrane-bound complex between 
FVIIIa and FIXa complex proteolytically activates factor X (FX), and then converts 
prothrombin to thrombin [82, 86, 87]. The proteolytic reaction rate hastens by nearly 5 
orders of magnitude when it is localized onto the negatively charged membrane surface 
with fixed protein conformation in complex with FVIIIa and FVa [89]. 
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Figure 1.6 Crystal structure of factor VIII (FVIII). The mature VWF has the domain 
structure A1-A2-B-A3-C1-C2 [82, 85]. The A1-A2 domains are present in the heavy 
chain (HC) with a molecular weight varying between 90 kDa and 200 kDa [84], while 
the domains A3-C1-C2 form the light chain (LC) with a molecular weight of 76 kDa 
[86]. A region of the C2 domain contains a membrane binding site of FVIII and the site 
of interaction with VWF [87]. FVIII circulates as a series of noncovalent heterodimers 
with VWF, produced by proteolytic cleavage at the B-A3 junction or within the B 
domain [88]. 
 
1.2 Integrin α4β7 
Lymphocytes circulating in the blood must leave the bloodstream to enter lymphoid 
organs or areas of inflammation. This elaborative process, termed lymphocyte 
extravasation, involves the stages of tethering or rolling, cell activation, firm adhesion, 
and finally transendothelial migration [90]. When this adhesive process is not under 
proper control, it can cause severe immune disorders such as psoriasis, multiple 
sclerosis, and inflammatory bowel diseases (IBD).  Among the lymphocyte surface 
molecules involved in this process, the α4 integrins (including α4β1 and α4β7) can 
mediate both rolling and firm adhesion. In this thesis, the integrin α4β7 is used as a kind 
of complexed protein to demonstrate the application of the newly developed SpyTag 
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method, as well as a model to further investigate the molecular and biophysical 
mechanisms underlying cell rolling and firm adhesion mediated by integrins [91]. 
 
Figure 1.7 Structure of integrin α4β7. Global conformational rearrangements in α4β7 
integrin extracellular domains upon activation. The three conformational states of α4β7 
and their contributions to lymphocyte-endothelial adhesion are shown. There may be 
an intermediate headpiece state shown by the broken line. 
Integrin α4β7 is a heterodimeric transmembrane molecule, held together by non-
covalent association of the α4 (MW 130–210 kDa) and β7 (MW 95–130 kDa) subunits 
(Figure 1.7) [92]. The N-terminal region of the α4 subunits is made up of seven repeats 
that form a “β-propeller” structure, which non-covalently associates with a Rossmann 
folded “I-like domain” in the N-terminus of the β subunit. The I-like domain consists 
of a metal ion-dependent adhesion site (MIDAS) that binds to negatively charged 
residues in ligands [93]. α4β7 mediates the homing of lymphocytes to lymphoid tissues 
by binding MAdCAM-1, the natural ligand for α4β7, expressed on the endothelium in 
mucosal lymphoid tissues such as lamina propria, Peyer’s patches, and mesenteric 
lymph nodes [94]. MAdCAM-1 has two NH2-terminal Ig domains (D1 and D2), which 
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are directly involved in integrin binding, and a more C-terminal, membrane-proximal, 
mucin-like region (Figure 1.7) [94]. The most crucial interaction in the stabilization of 
the α4β7–MAdCAM-1 complex appears to be the electrostatic interaction between Asp-
42 of domain 1 (D1) of MAdCAM-1 and the chelated Mg2+ ion of the β I-like domain 
[95].  
Like most integrins, affinity regulation is an important functional feature of α4β7. 
On resting lymphocytes, α4β7 mediates transient adhesion or cell rolling, while upon 
activation by chemokines and intracellular signals, the strength of the α4β7/ligand 
complex is drastically increased within sub-seconds, resulting in a prolonged lifetime 
of the α4β7/ligand bond. This activation leads to firm adhesion [96, 97]. Induction of 
high affinity integrin is proposed to be initiated by the unclasping and separation of the 
integrin α and β cytoplasmic tails followed by changes in the global conformation of 
the whole integrin molecule including an axial movement of the C-terminal α7 of the β 
I-like domain and a 60° outward swing of the β hybrid domain (Figure 1.7) [93, 98, 99]. 
Recent studies have shown that lymphocyte rolling is not mediated by the bent integrin 
conformer, but the extended conformer with a closed head piece. A recent structural 
study has suggested there might exist additional intermediate head piece states that are 
less active than the fully open head piece. These physiologically induced alterations in 
the distinct phases of adhesion can be mimicked by the manipulation of the divalent 
cation concentrations in vitro [100], or mutation of the metal ion binding sites in the β7 
I-like domain [101]. It is unclear if and how chemokine activation is different from 
cationic activation in terms of the affinity enhancement and structural change.  
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1.3 SpyTag–SpyCatcher 
The methods of tagging the desired protein with peptides (such as His6, Myc, HA, 
and FLAG) or biotin have been widely used by researchers for protein immobilization 
in single-molecule experiments [102–105]. However, the bonds formed in this 
traditional way are usually non-covalent, which means that the binding has low 
mechanical strength and is thermal dynamically unstable, and the reaction is reversible. 
Besides, due to the non-specificity of the bonds, these methods cannot eliminate the 
non-specific interaction between the protein and the polystyrene bead in a single-
molecule system. In the experiments, two different kinds of binding methods at two 
ends of the protein are usually required to prevent its two ends binding to one site. 
Recently, Mark Howarth et al. [36] proposed a new tagging method where the 
formation of a rapid covalent bond occurs without using chemical modification, 
artificial amino acids, or cysteines. They obtained a peptide tag of 13 amino acids 
(termed SpyTag) by splitting the Streptococcus pyogenes CnaB2 domain. The SpyTag 
is a C-terminal peptide containing amino acid residue Asp117, while the SpyCatcher is 
an N-terminal protein fragment containing amino acid residue Lys31 [36, 106]. The 
SpyTag and its partner SpyCatcher associate specifically and spontaneously by forming 
an isopeptide bond between Lys31 and Asp117 [103, 104, 107]. The bond is a type of 
covalent bond. A rational modification of the remaining protein fragments from the 
splitting of CnaB2 is shown in Figure 1.8. This reaction proceeds spontaneously, 
rapidly, and efficiently. Moreover, the SpyTag/SpyCatcher bonds have a high 
mechanical stability with a lifetime of more than one day, and a high mechanical 
strength of 131 pN [36]. The specific binding between SpyTag and SpyCatcher allows 
potential simplification of single-molecule force spectrum experiments. 
17 
 
 
Figure 1.8 SpyTag–SpyCatcher interaction. Streptococcus pyogenes (Spy) CnaB2 is 
split into two fragments, a large N-terminal fragment (SpyCatcher, left) and a smaller 
C-terminal peptide fragment (SpyTag, right). The SpyTag is a C-terminal peptide 
containing amino acid residue Asp117, while the SpyCatcher is an N-terminal protein 
fragment containing amino acid residue Lys31 [36, 106]. The SpyTag and its partner 
SpyCatcher associate specifically and spontaneously by forming an isopeptide bond 
between Lys31 and Asp117 [103, 104, 107].  
 
1.4 Single-Molecule Kinetic Mechanisms and Models 
Many biological molecules, such as a single-stranded DNA (ssDNA), a double-
stranded DNA (dsDNA), a double-stranded RNA (dsRNA) and polypeptides (proteins), 
display a significant flexibility over long distances, while every small segments remain 
rigid. To characterize the elastic and mechanical properties of the chain-like 
biomolecules, the worm-like chain (WLC) model (sometimes referred to as the Kratky–
Porod model) is usually utilized. Fitting the force-extension data from the single-
molecule pulling experiments to WLC model gives the contour length Lc, the 
persistence length Lp, and sometimes the elastic stretch modulus S, and the twist rigidity 
C. 
To characterize the natural energy landscape of interactions or different states 
(usually two states) of molecules, single-molecule pulling experiments are performed 
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in a force-ramp mode (with constant pulling velocities) or force-clamp mode (with 
constant pulling forces). Two well-known models, i.e., the Bell–Evans model and the 
Dudko model, derived from the Kramers theory can be used to extract the following 
parameters: (1) the spontaneous off/unfolding/refolding/dissociation rate or the 
intrinsic rate coefficient 𝑘0; (2) the distance between the native state and the transition 
state along the reaction coordinate, i.e., the location of the transition state or the barrier 
width Δx‡; (3) the barrier height or the free energy of activation ΔG. 
 
1.4.1 Worm-Like Chain (WLC) Model 
The worm-like chain (WLC) model (sometimes referred to as the Kratky–Porod 
model) is a continuous model used to characterize the behavior of semi-flexible 
polymers. Many biological molecules, such as a single-stranded DNA (ssDNA), a 
double-stranded DNA (dsDNA), a double-stranded RNA and proteins, display a 
significant flexibility over long distances, while every small segments remain rigid. 
It assumes polymers to be an idealized, macroscopic, and circularly-symmetric 
beam elements with a flexural rigidity. With successive monomers constrained to point 
in nearly the same direction, the isotropic polymer chain is continuously flexible. It is 
different from the freely-jointed chain model, which assumes the flexibility only 
between discrete segments [108, 109]. The WLC model has been widely used in 
analyzing the elastic and mechanical properties of the chain-like biomolecules, and has 
developed some variations [11, 31, 110–115]. 
The basic inextensible WLC model describing the relation between the polymer’s 
extension and the applied force is approximated by the following interpolation formula 
[31] 
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where 𝐹(𝑥) is the applied force on the polymer chain, x is the end-to-end distance, 𝐿𝑐 
is the contour length, 𝐿𝑝 is the persistence length of the polymer, kB is the Boltzmann 
constant, and T is the absolute temperature. In this formula, the polymer is treated as 
inextensible and the twisting effect is ignored. In molecular physics, the contour length 
𝐿𝑐  of a polymer chain is its maximum length when possibly extended, and the 
persistence length 𝐿𝑝 is defined as the length over which correlations in the direction 
of the tangent are lost, which quantifies the rigidity of the chain. An example of fitting 
force-extension data to WLC model is shown in Figure 1.9. The figure shows a typical 
force-extension trace of pulling the glycoprotein Ib-IX complex. Blue line is the 
approaching trace, and the red line is the retracting trace, i.e., the pulling curve. Two 
dashed green lines are the WLC fits to two sections of the red pulling curve according 
to Eq. (1.1). Two different fitted contour lengths from the fittings would give a contour 
length increment Δ𝐿𝑐 indicating the extension of the unfolding. 
In some polymers, the elastic response of the polymers cannot be neglected under 
stretching. Two extensible worm-like chain (eWLC) models were derived depending 
on the magnitude of the applied force. 
For low forces 𝐹 < ~10 pN, but has limitations near 𝐹 ≈ 0.1 pN), there is the 
following interpolations formula [111] 
where parameters F, x, Lc, Lp, kB, and T are the same as these in Eq. (1.1), while the 
new parameter S is the elastic stretch modulus, which accounts for the enthalpy term. 
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Figure 1.9 An example of fitting the force-extension data to the WLC model. It shows 
a typical force-extension trace of pulling the glycoprotein Ib-IX complex. Blue line is 
the approaching trace, and the red line is the retracting trace, i.e., the pulling curve. Two 
dashed green lines are the WLC fits to two sections of the red pulling curve according 
to Eq. (1.1). Two different fitted contour lengths from the fittings would give a contour 
length increment Δ𝐿𝑐 indicating the extension of the unfolding. 
For high forces, the following approximation is available [110] 
where all the parameters are same as these in Eq. (1.2). 
To take into account the sequence composition and a force-dependent twist-stretch 
coupling, a twistable worm-like chain (tWLC) model was built by expanding the eWLC 
model to the following approximation [115] 
where F, x, Lc, Lp, kB, and T are the same as these in Eq. (1.1), C represents the twist 
rigidity, and g(F) is the twist-stretch coupling [116–118]. 
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1.4.2 Kramers Theory 
In 1940, Kramers derived the first theory to calculate the rate of chemical reactions 
using the Brownian motion model [35, 119]. In this theory, chemical reactions are 
treated as diffusion problems. Based on a derivation of the Fokker–Planck diffusion 
equation [120] for the Brownian motion in phase space, in the presence of a nonlinear 
potential field, Kramers predicted the probability of escape (or called “rate of escape”) 
k depending on the temperature T and the friction γ. In the model of chemical reactions, 
a classical particle of mass M moves in a one-dimensional asymmetric double-well 
potential 𝑈(𝑥) (Figure 1.10). Along the reaction coordinate x, the particle has minima 
of potential at 𝑥𝑎 and 𝑥𝑐, denoting the reactant and product states, respectively. The 
local maximum point at 𝑥𝑏 separating these states corresponds to the transition state (or 
activated complex). In this simplified model, all the reacting and solvent molecules 
constitute a heat bath at temperature T. 
 
Figure 1.10 Asymmetric potential field with two metastable states. Asymmetric 
potential field 𝑈(𝑥) with two metastable states. There are two metastable wells at 𝑥𝑎 
and 𝑥𝑐, as well as a transition state at 𝑥𝑏 along the reaction coordinate 𝑥. Escape occurs 
via the forward rate 𝑘+ , and the backward rate 𝑘− , respectively. 𝐸𝑏+  and 𝐸𝑏− 
correspond to activation energies. 𝜔𝑎, 𝜔𝑏, and 𝜔𝑐 denote the angular frequency at each 
point, with parameter 𝜔0 = 𝜔𝑎. 
For a solvent with strong friction γ (large viscosity), Kramers derived the celebrated 
result of the escape rate from A to C, 
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where 𝜔0 = 𝜔𝑎, with 𝜔𝑎 and 𝜔𝑏 denoting the angular frequency at position 𝑥𝑎 and 𝑥𝑏, 
respectively; the thermal factor 𝛽 = 1/(𝑘𝐵𝑇), and the activation energy Δ𝐸 ≡ 𝐸𝑏+ =
𝑈(𝑥𝑏) − 𝑈(𝑥𝑎). 
In the limit as damping becomes very large (the Smoluchowski limit), i.e., for 
𝛾/2 ≫ 𝜔𝑏, using Taylor expansion, Eq. (1.5) turns to 
which predicts that the rate of escape k decreases inversely proportional to the friction 
γ. 
When friction γ is weak (small viscosity), Eq. (1.5) turns to 
 
1.4.3 Bell–Evans Model 
The earliest theory concerning the reaction rate was developed by Arrhenius [121], 
which is represented by the Van’t Hoff–Arrhenius law: rate of dissociation 𝑘 =
𝜈 exp(−𝐸0/𝑘𝐵𝑇) , where ν is the natural frequency of molecular collisions in the 
collision theory in vacuum, 𝐸0 is the free entropy term in the transition state theory, 𝑘𝐵 
is Boltzmann constant, and T is the absolute temperature. Later, Kramers derived the 
analytical formula for the rate of escape, but it was not applied until about thirty years 
later due to the unavailability of experimental techniques. Kramers presented the 
reaction kinetics in liquids [35]. In 1978, Bell first proposed the phenomenological 
model to describe the rate of bond dissociation under external force load [122] by 
extending the kinetic theory of the strength of solids [123] and the transition state theory 
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for reactions in gases introduced by Eyring and others [119]. Later Evans refined the 
theory by deriving the dependence of adhesion (the most probably or most likely 
rupture force) on the force loading rate [33]. 
A simple assumption is that the applied external force F acts directly along the 
reaction coordinate, i.e., the height of the transition-state energy barrier Δ𝐸 depends 
linearly on the applied force F and a constant distance Δx‡ between the native 
equilibrium state and the transition state,  
Based on Eq. (1.8), Evans et al. [33] derived the well-known force-dependent 
dissociation rate: 
where 𝜔min  represents the angular frequency of the metastable state, 𝜔max is the 
positive valued angular frequency of the transition state at the barrier, γ is the damping 
relaxation rate, 𝑘0 is the zero-force natural off rate, 𝑘𝐵 is Boltzmann constant, T is the 
absolute temperature, and 𝛽 = 1/(𝑘𝐵𝑇). 
The force-dependent lifetime of the bonds is the reciprocal of the force-dependent 
dissociation rate k(F), i.e., 
where 𝜏0 = 𝑘0
−1 is the intrinsic lifetime, corresponding to zero external force. 
Taking logarithm of Eq. (1.9) and Eq. (1.10) leads to 
We can see that Δx‡ and 𝜏0 (or 𝑘0) can be extracted by linear fitting the lifetime-
force data from constant-force experiments. 
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The change of existing bonds NB with time has the relation with the dissociation 
rate k: 
The number of intact bonds NB(t) is giving by integrating Eq. (1.12) 
Assuming that the applied force F is a reversible continuous function of time t, t 
can be replaced by F, yielding the following expression: 
Then the number of dissociated bonds ND at time t, under applied force F, is given 
by 
The probability p(F) that the bonds break under external force F is given by dND/dF: 
where ?̇?(𝐹) = d𝐹/d𝑡  is called the force loading rate [122]. It can be proved that 
∫ 𝑝(𝐹)d𝐹
∞
0
= 1. In the Bell–Evans model, substituting Eq. (1.9) into Eq. (1.16) leads 
to 
Therefore, the most probable rupture force 𝐹∗ can be obtained by the derivation: 
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Assuming that the force loading rate ?̇? is independent of the applied force F, like 
the situation in constant pulling speed experiments, a linear dependence of 𝐹∗ on the 
logarithm of the loading rate ?̇? is predicted: 
According to Eq. (1.19), we can extract the single-molecule kinetic information, i.e., 
the spontaneous dissociation rate 𝑘0 and the location of the transition state Δx
‡, when 
given the distribution of the rupture forces and the corresponding loading rates. That is 
where m and b denote the slope and the y-intercept from the linear fitting of 𝐹∗ to ln ?̇? 
using least squares. 
Sometimes flexible linkers are used in the pulling experiments, the force loading 
rate under investigation is continuously changing when stretching the molecule. In this 
situation, the assumption of independence between ?̇? and F is not fulfilled, then Eq. 
(1.19) is only an approximate description. 
It is also reported that the mean force ?̅?  and the median force Fm from the 
distribution can be used to extract the kinetic parameters Δx‡ and 𝑘0 [124, 125], with 
Recently in 2013, Sergey Sekatskii et al. [126] proposed one way of first-order 
correction to the Bell–Evans model. In the Bell–Evans model, Eq. (1.8) was used with 
the assumption of linear independence of the barrier height Δ𝐸 on the applied force F 
and a barrier width Δx‡ between the native equilibrium state and the transition state, 
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which requires a special shape of the interaction landscape. They employed an 
approximation of any interaction potential shape by first two terms of the Taylor 
expansion, i.e., 𝑈min = 𝑎min𝑥
2 + 𝑏min𝑥
3 + 𝑂(𝑥4)  and 𝑈max = 𝑎max𝑥
2 + 𝑏max𝑥
3 +
𝑂(𝑥4), and obtained the most probable bond rupture force 
where 𝐶 = 3𝑏min/(4𝑎min
2 ) + 3𝑏max/(4𝑎max
2 ) , substituting ?̃? = 𝛽Δ𝑥‡/𝐶  into Eq. 
(1.22) gives 
with the condition 𝐶 ∙ 𝐹∗ ≪ 1, i.e., 𝐹∗ ≪ |?̃?|/𝛽Δ𝑥‡. With a rough estimation of Δ𝑥‡ 
~0.1 nm [127-130], and |?̃?| ~10, the most probable force should be smaller than 400 
pN [126]. When 𝐶 = 0, Eq. (1.23) turns to be the Bell–Evans law (Eq. (1.8)). 
They [126] also reported the mean rupture force 〈𝐹〉 in the approximation: for 
positive C, 
and for negative C, 
where 𝛾 = 0.5772 … is the Euler–Mascheroni constant. 
The variance of mean rupture force is 
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There are also some new unified systematic theories considering the influence of 
fast force loading rates, such as one described in [131]. 
 
1.4.4 Dudko Model 
Based on the Kramers theory and certain scaling laws obtained by Garg [132] for 
high forces, Dudko et al. [133] built a unified framework for extracting kinetic 
information from single-molecule force spectroscopy experiments, which is also a 
phenomenological theory. 
 
Figure 1.11 Effect of the applied external force on a single-well free-energy surface. 
(A) Intrinsic free-energy surface 𝑈0(𝑥) with barrier width Δ𝑥
‡ between the native state 
and the transition state along the reaction coordinate, activation free energy Δ𝐺, and 
inflection point 𝑥∗ ; (B) The activation energy Δ𝑈(𝐹) of the combined free-energy 
surface decreases, 𝑈(𝑥)  =  𝑈0(𝑥) − 𝐹𝑥, due to the presence of an external force 𝐹, 
and the reaction rate 𝑘(𝐹) will increase (larger than spontaneous reaction rate 𝑘0). 
In the model, a molecule moves on a combined free-energy surface, with potential 
along the pulling direction x, where 𝑈0(𝑥) is the free energy, and F is the exerted 
pulling force. In single-well model, 𝑈0(𝑥) has a lowest single well at 𝑥 = 0, and a 
barrier at 𝑥 = Δ𝑥‡ of height Δ𝐺. Under an external force F, the barrier height Δ𝑈(𝐹) 
decreases, shown in Figure 1.11. 
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From Kramers theory [35], the force-dependent off rate k for sufficiently high 
potential barriers is predicted as 
For constant speed experiments (force-ramp mode), the external pulling force is 
𝐹(𝑡) = 𝐾 ∙ 𝑣𝑡 , where K is the spring constant for the stiff molecular system. The 
combined free-energy surface is given by 
using the first-order Taylor expansion for a soft effective spring 𝐾 ≪ 2Δ𝐺/Δ𝑥‡
2
. 
Substituting Eq. (1.29) to Eq. (1.28) gives 
To get an analytical formulation for k, two single-well model free-energy surfaces 
𝑈0(𝑥) are considered, where the force grows linearly with time: 
The cusp surface [134]: 
The linear-cubic surface: 
The force-dependent dissociation rate k(F) can be derived in a unified form [133]: 
In this expression, k0, Δx‡, and ΔG are the intrinsic off rate, the distance between 
the native state and the transition state along the reaction coordinate, and the apparent 
free energy of activation in the absence of an external force, respectively. ν is a scaling 
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factor, which specifies different kinds of free-energy surface profile. For 𝜈 = 1/2, 
formula (1.33) corresponds to the cusp surface described by Eq. (1.31), either a 
harmonic well or barrier; for 𝜈 = 2/3, formula (1.33) corresponds to the linear-cubic 
surface described by Eq. (1.32); for 𝜈 = 1, formula (1.33) returns to the Bell–Evans’ 
formula, exactly the same as Eq. (1.19), which means that the Bell–Evans model is a 
special case of Dudko model. 
The lifetime 𝜏(𝐹) = 𝑘(𝐹)−1 is given by 
If ΔG is calculated in unit of 𝑘𝐵𝑇, expression (1.34) changes to 
where 𝜏0 is the intrinsic lifetime of the bonds. 
Taking the logarithm of each side of Eq. (1.33) or Eq. (1.34) gives the following 
new equation: 
which is not a simple linear equation like Bell–Evans model (Eq. (1.19)). This equation 
is valid only when the rupture force F is below a critical force 𝐹𝑐 = Δ𝐺/(𝜈Δ𝑥
‡), where 
the barrier vanishes, or Eq. (1.36) would involve complex values due to the logarithm 
function. 
In the Dudko model, Eq. (1.34) or Eq. (1.36) is used to extract the kinetic properties, 
including 𝑘0 (or 𝜏0), Δ𝑥
‡, and Δ𝐺. In a single-molecule experiment, either pulling with 
a constant speed (force-ramp mode) or a constant force (force-clamp mode), 𝑘(𝐹) (or 
𝜏(𝐹)) and F can be obtained directly or indirectly from the experimental results. 
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Under the quasi-adiabatic approximation, the transformation from constant speed 
experiments to constant-force experiments is given by [34, 133, 135] 
where 𝑝(𝐹|𝑣)  is the rupture-force probability density distribution measured at the 
constant pulling speed v, 𝜏(𝐹) is the lifetime at the constant force F, and ?̇?̇(𝐹|𝑣) is the 
loading rate at the speed v. This transformation is applicable to all kinds of underlying 
free-energy surface. For each pulling speed v (or loading rate ?̇?̇(𝐹)), a set of (𝐹, 𝜏(𝐹)) 
pairs are obtained according to Eq. (1.37), and it is predicted that different sets of 
(𝐹, 𝜏(𝐹)) from different speeds, should collapse onto one single master curve over a 
wide range of rupture forces. 
Consider an experimental rupture-force histogram obtained at a constant speed v, 
the histogram has N bins of width Δ𝐹 = (𝐹max − 𝐹min)/𝑁. The number of counts in 
the ith bin is 𝑐𝑖 , 1 ≤ 𝑖 ≤ 𝑁 , then the total counts is 𝐶 = ∑ 𝑐𝑖
𝑁
𝑖=1 , resulting in the 
probability 𝑃(𝐹𝑖) = 𝑐𝑖/𝐶, and the density 𝑝(𝐹𝑖) = 𝑐𝑖/(𝐶 ⋅ Δ𝐹). Thus, substituting to 
Eq. (1.37) leads to (the Dudko–Hummer–Szabo equation) 
where 𝐹𝑖 = 𝐹min + (𝑖 −
1
2
) Δ𝐹, for 1 ≤ 𝑖 ≤ 𝑁 − 1; 𝜏(𝐹𝑁) =
𝑝(𝐹𝑁)/2⋅Δ𝐹
?̇?(𝐹𝑁)⋅𝑝(𝐹𝑁)
=
Δ𝐹
2?̇?(𝐹𝑁)
, for i 
= N. 
A quite general approximation of the relationship between the lifetime at the mean 
rupture force and the variance of the rupture-force distribution is given by [34] 
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This expression is derived from Eq. (1.37) by approximating the rupture-force 
distribution 𝑝(𝐹) as a normalized Gaussian distribution, and setting the rupture force 
𝐹 = 〈𝐹〉 . Actually, the real rupture-force distribution is not well described by the 
Gaussian distribution over the entire range of rupture forces, but the approximation of 
the lifetime at the mean force turns to be quite good. It is said that 𝜏(𝐹) from this 
relation can be derived from the highly non-Gaussian rupture-force distribution, with a 
numerical coefficient differing by <10% [34, 133]. 
Another simple approach for data set with substantial outliers is given by [34] 
where 〈𝐹〉 is the mean force, and 𝛿𝐹 = 𝐹3 − 𝐹1 is the interquartile range, i.e., 25% of 
the rupture forces are higher than F3 and 25% are lower than F1. 
The disadvantage of using these two approximations is that experiments on different 
pulling speeds are required to get a good fit between rupture forces and lifetimes, since 
only one pair of (〈𝐹〉, 𝜏〈𝐹〉) can be extracted from one constant-speed experiment. 
After getting data set (𝐹, 𝜏(𝐹)), non-linear least-squares fitting to logarithm of 𝜏(𝐹) 
in Eq. (1.36) on force F with several values of 𝜈 to estimate 𝜏0, Δ𝑥
‡, and Δ𝐺. If the 
fitting values of the tree parameters are insensitive to 𝜈 over a 𝜈 range which still lead 
to good fits, they are considered to be meaningful due to the independence of the exact 
profile of the free-energy surface. 
It is further preferred to consider the wellness of fitting results, by comparing the 
predicted force distribution with the experimental one. They started from the same 
equation in the Bell–Evans model (Eq. (1.16)) 
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Here, 𝑆(𝐹) is the bond survival probability that the molecular system keeps intact at 
time t. 
For constant pulling speed experiments, Eq. (1.16) can be converted to 
For small loading rate ?̇?, the mean rupture force 〈𝐹〉 and the variance 𝜎𝐹
2 are given 
asymptotically by [132, 133] 
where 𝛾 = 0.5772 …  is the Euler–Mascheroni constant, 𝜓′′(1) = −2.404 …  is a 
particular value of the tetragamma function, and ?̃?  = 𝛾2 − 3/𝜋2𝜓′′(1) ≈  1.064 [133, 
136]. For 𝜈 = 1  corresponding to the phenomenological theory, the variance 𝜎𝐹
2  is 
independent of the pulling speed v. Therefore, the phenomenological approach is 
invalid if the experimental variance changes for different pulling speeds. 
Figure 1.12 shows an example of using the Dudko model to analyze the 
experimental data. Experimental data is from the pulling of polyprotein (GB1)8 in PBS 
buffer with 0M GdmCl and 30% glycerol, at a variety of velocities (~0.1 μm/s, ~0.2 
μm/s, ~0.5 μm/s,  ~1 μm/s, ~2 μm/s) using AFM [137]. The symbols of same color (red, 
yellow, blue, puple, and green) are from the same pulling speed. At each pulling speed, 
several (𝐹, 𝜏(𝐹)) pairs are obtained by transforming the unfolding force histogram 
(inset) according to Eq. (1.38). It can be seen that these (𝐹, 𝜏(𝐹)) pairs from different 
pulling speeds do collapse onto a same master curve. Least squares fitting (black line) 
to the data yields the estimations of 𝜏0, Δ𝑥
‡, and Δ𝐺, which are further used to predict 
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the force histograms. The inset is an unfolding force histogram measured at speed v = 
520 nm/s. Using the parameters from the fitting to the Dudko model, we obtain the 
predicted force distribution (inset, red line), which agrees well with the experimental 
one. 
 
Figure 1.12 An example of the application of the Dudko model. Experimental data is 
from the pulling of polyprotein (GB1)8 in PBS buffer with 0M GdmCl and 30% 
glycerol, at a variety of velocities (~0.1 μm/s, ~0.2 μm/s, ~0.5 μm/s,  ~1 μm/s, ~2 μm/s) 
using AFM [137]. The symbols of same color (red, yellow, blue, puple, and green) are 
from the same pulling speed. At each speed, several (𝐹, 𝜏(𝐹)) pairs are obtained from 
the transformation of the unfolding force histogram (inset) according to Eq. (1.38). It 
can be seen that these (𝐹, 𝜏(𝐹)) pairs from different pulling speeds do collapse onto a 
same master curve. Least squares fitting (black line) to the data yields the estimations 
of 𝜏0 , Δ𝑥
‡ , and Δ𝐺 , which are further used to predict the force histograms. The 
predicted force distribution (inset, red line) agrees well with the experimental one. 
In AFM experiments, the force loading rate ?̇? = d𝐹/d𝑡 = 𝐾𝑣 is independent of F, 
when the linker effect is neglected. However, some experimental systems use 
intervening flexible linkers, like DNA handles, then the loading rate is a function of the 
applied force, i.e., ?̇? = ?̇?(𝐹). Considering the pulling process as a simple force-balance 
process, the force-dependent loading rate ?̇?(𝐹) is given by [138] 
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where v is the pulling velocity, K is the spring constant of cantilever in AFM 
experiments, l(F) is the force-dependent extension of the linker. 
For the WLC model, the extension l(F) of the flexible linker is approximately the 
solution of Eq. (1.1) 
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where F is the applied force, Lc is the contour length, and Lp is the persistence length of 
the WLC linker. By taking into account the first two terms in the low-force expansion 
of dl/dF with the limit 𝐹 → ∞, an approximate analytical Padé-like expression for the 
force-dependent loading rate ?̇? is given by [34] 
We can see that the second factor in the right hand side accounts for the link effect. 
If this part is ignored, the expression turns to the simple one ?̇? = 𝐾𝑣. It is reported that 
this expression is accurate to within ~3.5% [34]. 
For the analogous expression for a freely jointed chain (FJC), the force-dependent 
loading rate ?̇? is given by Ray et al. [138] 
where Lc is the contour length of the linker, K is the cantilever spring constant in AFM 
experiments, and the parameter 𝐹𝐾  =  𝑘𝐵𝑇/𝑎 where a is the Kuhn length of the linker. 
It is also noticeable that the loading rate approaches Kv under conditions of high force 
F, a short linker Lc, or a small spring constant K. 
Both the Bell–Evans model and the Dudko model are derived from Kramers theory, 
and both are phenomenal approaches. A comparison between the two models is shown 
in Table 1.1. 
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Table 1.1 Comparison between the Bell–Evans model and the Dudko model. 
In this Table, 𝐹, ?̇? and 𝐹∗ denote the force, the force loading rate, and the most 
probable force, respectively; k, k0, τ, and τ0 denote the off rate under force, the 
spontaneous off rate, the lifetime under force, and the intrinsic lifetime, 
respectively;  Δ𝑥‡  and Δ𝐺  denote the barrier width and height, respectively; ν is a 
scaling factor indicating different kinds of free-energy surface profile, and 𝛽 =
(𝑘𝐵𝑇)
−1 is a constant. 
 
1.5 Single-Molecule Force Measurements 
Single-molecule experiments are designed and carried out to measure the 
mechanical and biological properties of proteins, and molecular interactions [1, 2, 133]. 
A wide variety of single-molecule manipulation techniques have been developed since 
about fifty years ago, including atomic force microscopy (AFM) [4–8], optical tweezers 
[9–19], magnetic tweezers [20–27], and biomembrane force probes (BFP) [28–30]. 
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        
           
        
 
Parameters 
(known) 
force-ramp: β, ?̇?, 𝐹∗ 
force-clamp: β, F, τ 
β, F, 𝜏 
ν is preset to 1/2, 2/3 or 1 
Parameters 
(unknown) 
Δ𝑥‡, k0 (or 𝜏0) Δ𝑥
‡, 𝜏0, Δ𝐺 
Law 
force-ramp: 𝐹∗ ∝ ln ?̇? 
force-clamp: ln 𝜏 ∝ 𝐹 
𝜏 or ln 𝜏 is nonlinearly related to F and 
ln 𝐹 
Fitting 
methods 
least-squares linear 
fitting (simple) 
least-squares nonlinear fitting or 
Bayesian inference (complicated) 
Force-ramp 
experiments 
various pulling speeds 
for (?̇?, 𝐹∗) pairs from 
the force histograms 
one pulling speed for (𝐹, 𝜏) pairs from 
the transformation of the force 
histogram (Eq. (1.38)) 
Force-clamp 
experiments 
various constant forces 
for (𝐹, 𝜏) pairs 
same as these in the Bell–Evans model 
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There are some good reviews about these different techniques [22, 139–141]. 
Fluorescence resonance energy transfer (FRET) is also a widely used technique in 
biological and biophysical fields. Though FRET does not measure the force, its function 
of imaging can be used to measure the conformational changes of proteins [142], to 
detect the molecular interactions [143], and to obtain the information about metabolic 
or signaling pathways  [144]. A summary of the technical features of the three force 
spectroscopy techniques, including AFM, optical tweezers, and magnetic tweezers, and 
the imaging technique FRET is shown in Table 1.2. 
Table 1.2 Comparison of different single-molecule techniques 
 AFM 
Optical 
Tweezers 
Magnetic 
Tweezers 
FRET 
Spatial resolution 
(nm) 
0.5–1 0.1–2 5–10 0.01–0.1 
Temporal 
resolution (s) 
10-3 10-3–10-4 10-1–10-2 10-10–10-9 
Stiffness 
(pN·nm−1) 
10–105 0.005–1 10-3–10-6 ― 
Force range (pN) 10–104 0.1–102 10-3–102 ― 
Displacement 
range (nm) 
0.5–104 0.1–105 5–104 1–10 
Time scale (s) 10-3–102 10-4–103 10-3–105 ― 
Probe size (μm) 100–250 0.25–5 0.5–5 ― 
Typical 
applications 
High-force pulling 
and interaction 
assays 
3D manipulation 
Tethered assay 
Interaction assay 
Tethered assay 
DNA topology 
Imaging 
Features 
High-resolution 
imaging 
High force range 
Active force clamp 
Low noise and 
drift 
Dumbbell 
geometry 
Active/passive 
force clamp 
Force clamp 
Bead rotation 
Specific 
interactions 
Fast and high-
resolution 
imaging 
 
Limitations 
Large high- 
stiffness probe 
Large minimal 
force 
Random 
attachment 
geometries 
Photodamage 
Sample heating 
Bulky handles 
Difficult to 
manipulate 
molecule 
Large particles 
Bulky handles 
The optical 
spatial 
resolution by 
the Rayleigh 
criterion 
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In this table, the properties of AFM, optical tweezers, and magnetic tweezers are 
summarized from ref. [22, 141]. The properties of FRET are summarized from ref. 
[145–147]. 
 
1.5.1 Mini-Optical Tweezers 
Our lab owns a mini-optical tweezers apparatus, which can measure forces as high 
as 150 pN, with sub-piconewton force resolution, sub-nanometer distance resolution, 
and 1 millisecond time resolution. The scheme of mini-optical tweezers is shown in 
Figure 1.13. The fundamental principle is that, a light beam carries momentum flux, 
and generates a force 𝐹 = d𝐏/d𝑡 = 𝑊/𝑣 when it is absorbed, where 𝑊 is the power 
of the light beam and 𝑣 = 𝑐/𝑛 is the speed of light in the medium. When a light beam 
is refracted by an object, its momentum changes with the change in beam direction, 
thus exerting a force with an equal magnitude and an opposite direction to that of the 
momentum change on the object. The object, usually a transparent particle of high 
refractive index like a polystyrene micro-bead, is trapped at a laser focus by virtue of 
the way it refracts the photons and changes their momenta. When the trapped sphere 
deviates its equilibrium trap position (at the light focus) under an external force 𝐹, the 
flux of light exiting the back side of the trap will undergo a change equal to the force, 
and the sphere will leave the light focus center to sustain the force balance. After 
performing the force and distance calibration of the mini-tweezers system, we are able 
to obtain the relationship between the external force and the distance deviation from the 
light focus center. 
In the mini-optical tweezers system, there are two main parts. The first one is the 
optical laser system, where a counter-propagating beam geometry is used to form a 
symmetric trap with 2 lasers focused to the same point. The other one is the well-
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designed reaction chamber with three channels. The top and bottom channels are used 
for injecting micro-spheres (usually 𝑑 = 2  μm), where experimental constructs are 
coated. The middle channel provides the zone and buffer solution for reactions. During 
an experiment, one micro-spherical bead is sucked on the tip of the micropipette, and 
is immobilized, while the other bead is captured by the optical trap and controlled to 
move back and forward to make contact with the first bead. The two kinds of beads are 
coated with proteins or other constructs, depending on different experimental systems. 
The optical tweezers have a high advantage in the resolutions of force, distance, and 
time. They allow to perform single-molecule force measurements in both the force-
ramp mode and the force-clamp mode, through different settings of the software. 
 
Figure 1.13 Mini-optical tweezers system. (A) Schematic diagram of the mini-optical 
tweezers system. A counter-propagating beam geometry is used to form a symmetric 
trap with two lasers focused to the same point. The position and force information is 
measured by the position-sensitive photo detector (PSD). (B) The chamber for single-
molecule experiments. The chamber have three channels. One kind of bead is injected 
into the top channel, passes to the middle channel through the pipeline, and is captured 
by the optical trap. Then it is brought to the position of the micropipette, and sucked by 
the micropipette. Another kind of bead is injected into the bottom channel, and is 
captured by the trap in a similar way. The bead is further controlled by the trap to move 
in retract-approach cycles. (C) A photo of the CCD screen from the experiment. It 
shows that one bead is captured by the optical trap, and another bead is sucked by the 
micropipette. 
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1.5.2 Atomic Force Microscopy (AFM) 
We also use on a home-built atomic force microscopy (AFM) for single-molecule 
force measurements, shown in Figure 1.14. In this AFM system, a beam of laser is 
reflected by the backside of the sensitive cantilever and detected by a position sensitive 
detector (PSD) with two closely spaced photodiodes. A deformation of the cantilever 
happens when it presses on a hard surface of the substrate or a tether is picked up by 
the cantilever tip. The difference in the signal measured by the photodiodes is 
proportional to the angular displacement of the cantilever, and then converted to force 
after the calibration of the cantilever. The displacement and pulling speed are controlled 
by the piezo. The time information can also be controlled and recorded. For the AFM 
experiments, we use a fast-speed camera (The Imaging Source DMK 21AF04.AS) to 
help locate the cantilever and align the laser. 
 
Figure 1.14 Schematic diagram of the home-built AFM. A beam of laser (red line) is 
reflected by the backside of the sensitive cantilever and detected by a position sensitive 
detector (PSD) with two closely spaced photodiodes. A deformation of the cantilever 
happens when it presses on a hard surface of the substrate or a tether is picked up by 
the cantilever tip. The difference in the signal measured by the photodiodes is 
proportional to the angular displacement of the cantilever, and then converted to force 
after the calibration of the cantilever. The displacement and pulling speed are controlled 
by the piezoelectric actuator. 
40 
 
To avoid the shifting of the gold-coated coverslip, vacuum grease is placed on its 
bottom. The holder where the cantilever is fixed is controlled by the piezoelectric 
actuator. The piezoelectric actuator brings the holder down to approach and press the 
coverslip’s surface. By setting a trigger signal, the piezo state will stop to avoid 
damaging the cantilever. At this point, we can set a contact time, also called dwell time, 
to obtain a higher probability for the cantilever tip binding to the sample (usually 1 s to 
5 s). The part of the protein that is picked up by the tip is random. The setting of dwell 
time depends on each experiment, and too long of a dwell time will require significantly 
more time to finish, especially when the pulling speed is very low (~0.1 μm/s). Then 
the cantilever moves upward to retract within a distance of 𝑍 range. We are able to 
observe the conformational changes (such as unfolding and refolding) of the protein 
samples, or the unbinding of bonds. 
Though the optimized mini-optical tweezers have many advantages over traditional 
AFM, they cannot reach high external forces. That is to say, when we want to measure 
high unbinding or rupture forces of bonds/interactions, we have to use AFM to obtain 
the information. 
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Chapter 2: Identification of a Juxtamembrane Mechano-
sensitive Domain in the Platelet Mechanosensor Glycoprotein 
Ib-IX Complex 
How glycoprotein (GP) Ib-IX complex on the platelet surface senses the blood flow 
through its binding to the plasma protein von Willebrand factor (VWF) and transmits a 
signal into the platelet remains unclear. In this chapter, I will show that optical 
tweezers-controlled pulling of the A1 domain of VWF (VWF-A1) on GPIb-IX captured 
by its cytoplasmic domain induces unfolding of a hitherto unidentified structural 
domain prior to the dissociation of VWF-A1 from GPIb-IX. Additional studies using 
recombinant proteins and mutant complexes confirmed the existence of this quasi-
stable mechanosensitive domain (MSD) of ~60 residues in GPIb-IX and enabled 
localization of the MSD between the macroglycopeptide region and the transmembrane 
helix of GPIbα subunit. These results suggest that VWF-mediated pulling under fluid 
shear induces unfolding of the mechanosensitive domain in GPIb-IX, which may 
possibly contribute to platelet mechanosensing and/or shear resistance of VWF-platelet 
interaction. The identification of the mechanosensitive domain in GPIb-IX has 
significant implications for the pathogenesis and treatment of related blood diseases. 
 
2.1 Introduction 
The mechanical shear force generated by blood flow in the vasculature is an 
important factor that mediates physiological hemostasis and pathological thrombosis. 
The induction of platelet aggregation by the elevated shear stress requires the VWF and 
its association with glycoprotein (GP) Ib-IX and GPIIb/IIIa, both of which are platelet-
specific receptor complexes [50, 51]. VWF in flowing blood or immobilized at the 
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damaged vessel wall responds to shear stress and exposes its A1-A2-A3 domains [53, 
148, 149]. Concurrently, ligation of VWF under flow with the N-terminal domain of 
GPIbα, the major subunit in GPIb-IX, transmits a signal into platelet that eventually 
leads to activation of GPIIb/IIIa and aggregation of platelets [64, 150–152]. Although 
GPIb-IX has been recognized as the platelet mechanosensor for the past 20 years [52], 
how this receptor complex senses shear stress and converts this mechanical information 
into a protein-mediated signal that can be recognized and propagated has remained 
elusive.  
The GPIb-IX complex consists of GPIbα, GPIbβ and GPIX subunits in a 1:2:1 
stoichiometry [79, 80]. GPIbα contains, starting from the N-terminus, a leucine-rich 
repeat (LRR) domain that interacts with the A1 domain of VWF, a highly glycosylated 
macroglycopeptide region, a stalk region of about 60 residues, a pair of cysteine 
residues that connect to GPIbβ via disulfide bonds, a single-span transmembrane helix, 
and a relatively short cytoplasmic domain that is connected to the cytoskeleton through 
filamin A (Figure 2.4) [81]. GPIbβ and GPIX each contain an extracellular leucine-rich 
repeat domain that is much smaller than that of GPIbα, a transmembrane helix and a 
cytoplasmic tail [153]. GPIb-IX is a highly integrated complex, with each subunit 
interacting with one another through its transmembrane helices and membrane-
proximal extracellular domains (Figure 2.4) [77]. Crystal structures of the GPIbα N-
terminal domain in complex with VWF-A1 have been determined [75, 154]. Its 
association with VWF-A1 is classified as a catch-bond [155, 156] or flex-bond [114], 
which better facilitates the tethering of platelets to VWF under flow. However, 
numerous studies on the GPIbα N-terminal domain have not provided any evidence on 
how it transmits the VWF-binding signal into the platelet. This is largely because the 
GPIbα N-terminal domain makes no contact with the membrane-proximal parts of 
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GPIb-IX except through the long and relatively flexible macroglycopeptide region 
(Figure 2.4) [157]. There have been no reports of a highly glycosylated mucin-like 
region mediating a long-distance allosteric conformational change.  
Related to the elusive platelet mechanosensing mechanism is another puzzling, and 
again unanswered, question about the function of GPIbβ and GPIX. Previous studies 
have demonstrated that expression of GPIb-IX in CHO cells requires all three subunits; 
the surface expression level of GPIbα in the absence of GPIbβ and GPIX is drastically 
lower than that of GPIbα in GPIb-IX [158]. In principle, this explains why mutations 
causing Bernard–Soulier syndrome (BSS), a rare congenital bleeding disorder 
characterized by an abnormally low level of expression of functional GPIb-IX, are 
present in all three subunits [159–161]. The phenomenon of interacting subunits 
necessary for co-expression has been documented in other receptor complexes such as 
TCR-CD3 and integrins [162–165]. In those cases, all the involved subunits take on a 
critical role in signaling in addition to coexpression. In comparison, no additional 
functions have been proposed for the extracellular domains of GPIbβ and GPIX, which 
can change conformation in response to environmental changes [166]. 
In this chapter, we aim to examine mechanical properties of the membrane-
proximal mechanical sensitive domain (MSD) in GPIb-IX complex, rather than the 
membrane-distal Ibα ligand-binding domain as in earlier reports [114, 155]. Since 
individual juxtamembrane domains are not stable and are held together by the 
neighboring transmembrane domains [167–169], we set up the first single-molecule 
force measurement on the full-length GPIb-IX complex (Figure 2.4) [58, 170] using 
optical tweezers. Relatedly, a mammalian cell line stably expressing biotinylated GPIb-
IX has been established [58]. In this system, a 13-residue BioTag sequence that is 
specifically recognized and biotinylated by E. coli biotin ligase [171] was inserted into 
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a desired cytoplasmic domain of GPIb-IX thereby achieving site-specific biotinylation 
of the complex. The biotinylated GPIb-IX was immobilized to the streptavidin bead 
and used for the experiment. Recombinant A1 was attached to another bead through its 
hexa-histidine tag and a DNA handle [53, 114, 172]. Pulling on the immobilized GPIb-
IX with recombinant VWF-A1 induces unfolding of a domain in the juxtamembrane 
stalk region of GPIbα. This domain, hitherto unidentified and designated as the 
mechanosensitive domain (MSD), is structured but relatively unstable. Identification of 
this MSD in GPIb-IX has potential implications for the mechanism of platelet 
mechanosensing, in which GPIbβ and GPIX extracellular domains play a critical role.  
The key points in this chapter are: (i) Pulling of VWF A1 domain that is engaged 
to GPIb-IX induces unfolding of a hitherto unidentified mechanosensitive domain in 
GPIbα.  (ii) The spatial proximity of the mechanosensitive domain to GPIbβ and GPIX 
suggests a novel mechanism of platelet mechanosensing. 
 
2.2 Materials and Methods 
2.2.1 Materials 
HEK293 Tet-on 3G cell line was obtained from Clontech (Mountain View, CA). 
Recombinant hexahistidine-tagged VWF-A1 and thiol-activated 802-bp DNA handles 
were prepared using previously established protocols [53, 114]. Antibody WM23 was 
kindly shared by Dr. Michael Berndt. The monoclonal anti-GPIX antibody FMC25 was 
purchased from Millipore (Temacula, CA). Biotinylated antibody was prepared using 
sulfo-NHS-biotin (Thermo Scientific, Rockford, IL). 
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2.2.2 Cloning of Mutant GPIb-IX Constructs 
To facilitate molecular cloning, a DNA fragment that encodes the same protein 
sequence of human GPIbβ but lacks the GC-rich nucleotide sequence was synthesized 
by Genscript (Piscataway, NJ). The encoded GPIbβ included an HA tag at its N-
terminus as described in Section 0 [173]. Mammalian expression plasmid pBIG-5b 
(Genbank accession number KM042177) was generated by inserting the coding 
sequence of E. coli biotin ligase (BirA) into multiple cloning site (MCS) II of pBI 
(Clontech) and a DNA cassette comprising, from 5’ to 3’-ends, a 13-residue biotin 
acceptor peptide (BioTag)-encoding sequence [174], an internal ribosome entry site, 
and an enhanced green fluorescent protein (EGFP)-encoding sequence into MCS I of 
pBI. The new GPIbβ gene was inserted into pBIG5b as a NheI/NsiI fragment to 
generate pBIG5b-BirA/Ibβ/EGFP.  
To construct pBIG5b-Ibα/IX-biotag/mCherry, the gene fragment encoding GPIX 
was amplified, appended at the 5’-end with sequences encoding the myc tag and TEV 
protease cleavage sequence, and inserted into pBIG5b using the NheI/XhoI restriction 
sites. The resulting plasmid was digested by AgeI/BsrGI to replace the EGFP gene with 
mCherry. Subsequently, the pBIG5b-IX-biotag/mCherry plasmid was digested by 
EagI/SphI to replace the BirA gene with GPIbα. To enable ligation of the GPIbα 
fragment, the second SphI site in the MCSII was removed prior to ligation. Mutant 
GPIbα genes with altered MSD were subcloned into the pBIG5b-IX-biotag/mCherry 
plasmid in a similar fashion.  
To construct pcDNA-Ibα-biotag, the gene fragment encoding the BioTag sequence 
was inserted into the GPIbα cDNA to replace the sequence encoding residues Q519-
A532. The mutated GPIbα gene was ligated into the pcDNA-3.1(-) vector (Invitrogen, 
Carlsbad, CA) using the NheI/XhoI sites. The wild-type GPIX gene was ligated into 
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the pcDNA vector in a similar manner. All plasmids were confirmed by DNA 
sequencing. 
 
Figure 2.1 A mutant GPIb-IX in which a juxtamembrane residue in the GPIbα 
cytoplasmic domain was biotinylated. (A) Sequence of GPIbα-biotag, in which the 
cytoplasmic residues Gln519-Ala532 were replaced by the BioTag sequence 
(underlined). The transmembrane domain is shown in the grey box. (B) Formation of 
inter-subunit disulfide bonds and biotinylation of GPIbα in the GPIb-IX complex 
expressed in transiently transfected HEK 293 cells. Western blot experiments were 
performed as in Figure 2.2C–D. Lanes 1 and 3, cells expressing GPIbα/HA-
GPIbβ/GPIX; lanes 2 and 4, cells expressing GPIbα-biotag/HA-GPIbβ/GPIX. Figure is 
kindly provided by the collaborator Dr. Renhao Li. Use with permission.  
 
2.2.3 Expression of Biotinylated GPIb-IX and Mutants 
To establish a cell line stably expressing HA-GPIbβ, HEK293 Tet-on cells were co-
transfected by plasmids pBIG5b-BirA/Ibβ/EGFP and pUC19-puro using 
Lipofectamine 2000 (Invitrogen). The pUC19-puro plasmid was generated by ligating 
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the XhoI fragment of plasmid pTRE2pur (Clontech), which contains the puromycin N-
acetyl-transferase expression cassette, into pUC19 vector that had been modified by 
insertion of an oligonucleotide cassette to contain a single XhoI restriction site in its 
MCS. Beginning 1 day post-transfection, cells were cultured in the DMEM medium 
supplemented with 10% fetal bovine serum (FBS), 1% penicillin/streptomycin, 5 
µg/mL blasticidin and 2 g/mL puromycin for 3 weeks.  The surviving cells were 
treated with 3 g/mL doxycycline for 1 day before being sorted for EGFP fluorescence 
and surface expression of HA-GPIbβ detected by anti-HA antibody (Sigma-Aldrich, St. 
Louis, MO). The cells stably expressing BirA/HA-GPIbβ/EGFP were further 
transfected with the pBIG5b-Ibα/IX-biotag/mCherry vector, cultured for 3 weeks and 
sorted for stable surface expression of GPIbα detected by WM23, and EGFP and 
mCherry fluorescence. Alternatively, cells stably expressing HA-GPIbβ/BirA/EGFP 
were transiently transfected with pcDNA-Ibα-biotag and pcDNA-IX using 
Lipofectamine 2000.  
To induce expression of biotinylated GPIb-IX, the cells were cultured in the FBS-
free medium containing 3 µg/mL doxycycline and 100 µM d-biotin for 1 day. The cells 
were harvested and lysed in the lysis buffer (1% triton X-100, 5 mM CaCl2, 58 mM 
sodium borate, 10% protease inhibitor cocktail, 5 mM N-ethylmaleimide, pH 8.0; at 
approximately 1–2×104 cells/µL). The supernatant containing biotinylated GPIb-IX 
was further analyzed by Western blot and flow cytometry largely as described 
previously [166, 175, 176], or stored at −80 ˚C for the single-molecule force 
measurement. 
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Figure 2.2 Expression and biotinylation of GPIb-IX. (A) The altered GPIX cytoplasmic 
sequence that contains the engineered biotinylation site. Residues in the GPIX 
transmembrane domain are shown in a grey box, and added residues are underlined and 
labeled. (B) Overlaid flow cytometry histograms showing the surface expression of 
GPIbα, HA-tagged GPIbβ and GPIX-biotag in stably transfected HEK293 Tet-on cells. 
Prior to (thin traces) and after (thick traces) the induction of protein expression by the 
addition of doxycycline and biotin, the cells were stained by mouse IgG (control), anti-
GPIbα antibody WM23, anti-HA antibody, or anti-GPIX antibody FMC25 and detected 
by flow cytometry. (C) Formation of native inter-subunit disulfide bonds in the 
GPIbα/HA-GPIbβ/GPIX-biotag complex detected by Western blot. The cell lysate was 
resolved in an SDS gel under non-reducing (N.R.) or reducing (R.) conditions and 
transferred to the polyvinylidene difluoride (PVDF) membrane. The membrane was 
probed with WM23 followed by HRP-conjugated secondary antibody. The positions of 
molecular weight markers in the gel are marked on the left. (D) Expression of 
biotinylated GPIX-biotag in the cell detected by Western blot. Doxycycline (dox) and 
biotin were added, in combination as indicated, to the cells to induce protein expression 
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and biotinylation. The cell lysates were resolved in SDS gels and transferred to the 
PVDF membrane. The membranes were probed separately with (top) HRP-conjugated 
avidin, or (middle) anti-myc antibody and (bottom) anti-actin antibody followed by 
HRP-conjugated secondary antibody. Figure is kindly provided by the collaborator Dr. 
Renhao Li. Use with permission.  
 
2.2.4 Expression and Purification of Recombinant GPIbα Stalk Region (Ibα-
S) 
The DNA fragment encoding GPIbα residues Ala417-Phe483 was amplified from 
the GPIbα cDNA and later ligated into the pHex vector [80] as a BamHI/XhoI fragment. 
The DNA sequence was confirmed by sequencing. Ibα-S was expressed as a 
decahistidine-tagged glutathione S-transferase (GST) fusion protein from E. coli BL21 
cells and its purification by nickel affinity chromatography followed published 
protocols [80, 168]. After the fusion protein was cleaved by thrombin (5 units per mg 
of fusion protein), Ibα-S was separated from GST by preparative reverse-phase HPLC 
and stored at −80 ˚C as lyophilized powder [80]. Related proteins Ibα-cSc and Ibα-cS-
biotag were prepared in a similar manner. The purity of each protein was confirmed by 
SDS-PAGE and analytical HPLC, and its concentration was estimated using the dry 
weight method. 
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Figure 2.3 Expression and purification of the recombinant mechanosensory domains. 
(A) Preparative HPLC traces showing the separation of recombinant mechanosensory 
domains (Ibα-S and Ibα-cSc) from GST after thrombin digestion. The digestion mix 
was dissolved in 35% acetonitrile, 0.1% TFA. 10 mM DTT was added to the mixture 
containing Ibα-cSc or Ibα-cS-biotag. Both samples were filtered with 0.2-μm Nylon 
filter and injected to a Vydac reverse-phase C4 column followed by a gradient elution. 
Absorbance at both 220 nm (solid trace) and 280 nm (dashed) was recorded against 
time. The peaks of proteins of interest were marked. (B) Purified Ibα-S and Ibα-cSc 
were collected from HPLC, lyophilized and resolved in a 15% Bis-Tris SDS gel. The 
gel was stained by Coomassie blue. (C) Purified Ibα-cS-biotag (unbiotinylated or 
biotinylated, depending on its coexpression with biotin ligase) was resolved in 15% 
Bis-Tris SDS gel, and blotted by HRP-conjugated avidin (left) or stained directly with 
Coomassie blue (right). (D) Overlaid CD spectra of unbiotinylated Ibα-cS-biotag 
(dashed trace), biotinylated Ibα-cS-biotag (dotted trace) and Ibα-S (solid trace). Figure 
is kindly provided by the collaborator Dr. Renhao Li. Use with permission. 
 
2.2.5 Laser Optical Tweezers Measurement 
Biotin and digoxigenin (Dig) DNA handles were prepared as described previously 
[53, 114]. Dithiobis-nitrilotriacetic acid (NTA) (Dojindo, Rockville, MA) was first 
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reduced by Immobilized TCEP Disulfide Reducing Gel (Thermo Scientific), and then 
coupled to the activated biotin DNA handle via a disulfide bond. Recombinant Ibα-cSc 
was coupled to two pieces of DNA handle through the disulfide bonds as described 
previously [53, 114]. Carboxyl-polystyrene beads of 2.0-μm diameter (Spherotech, 
Lake Forest, IL) were covalently coupled with streptavidin (Invitrogen), anti-
digoxigenin Fab (Roche), or WM23 as described previously [53, 114]. To couple VWF-
A1 to the bead, streptavidin-coated beads were first incubated for 10 min with 1 nM 
biotin-DNA handle-NTA in TBS buffer (150 mM NaCl, 10 mM Tris·HCl, 5 mM NiCl2, 
pH 7.5) and then washed and incubated with 100 pM VWF-A1 for 15 min before 
experiment. In order to capture the biotinylated GPIb-IX, streptavidin-coated beads 
were incubated with 20 µL GPIb-IX-containing cell lysate for 10 min and washed with 
TBS buffer containing 1% triton X-100. Single-molecule pulling experiments were 
performed using an analytical mini-optical tweezers apparatus that has been used in 
several single-molecule unfolding/unbinding studies [17, 177, 178]. Force and bead-to-
bead distance were recorded at 200 Hz. When appropriate, the force-extension data was 
fitted to the WLC model. The lifetime of the bond as a function of force was estimated 
by the Dudko–Hummer–Szabo equation (Eq. (1.37) or Eq. (1.38)) [34]. 
 
2.2.6 Circular Dichroism Spectroscopy 
Purified Ibα-S or its variants were weighed and dissolved in 50 mM Tris·HCl, 50 
mM NaCl, 1 mM DTT, pH 7.4 buffer, or the same buffer containing various 
concentrations of urea, to a final concentration of 2.5 mg/mL. Far-UV circular 
dichroism (CD) spectra (190–260 nm) were collected on a JASCO J810 spectrometer 
using a 0.1-cm quartz cuvette at 20 ˚ C.  The step-wise wavelength was set to 0.5 nm/step. 
Each spectrum was scanned 5 times and corrected for background signal. 
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2.3 Results 
2.3.1 Force-Induced Unfolding of a Domain in the Full-Length GPIb-IX 
To enable single-molecule force measurement of full-length GPIb-IX, a new 
expression system was engineered to achieve site-specific biotinylation of GPIb-IX 
(Figure 2.2). Since the cytoplasmic domain of GPIX is not critical to the proper 
assembly of GPIb-IX [176], a 13-residue BioTag sequence in which a lysine residue is 
specifically recognized and biotinylated by E. coli biotin ligase [174] was appended to 
the C-terminus of GPIX (Figure 2.2, Figure 2.4, and Figure 2.7). Coexpression of the 
engineered GPIX (GPIX-biotag) with GPIbα, HA-tagged GPIbβ [173], and biotin 
ligase in human embryonic kidney (HEK)293 cells produced a well-assembled GPIb-
IX complex that was uniformly biotinylated at the cytoplasmic end of GPIX (Figure 
2.2). In our optical tweezers assembly (Figure 2.4), recombinant hexahistidine-tagged 
VWF-A1 was attached to an NTA-conjugated DNA handle. The other end of the DNA 
handle was immobilized to a 2-µm polystyrene bead via biotin-streptavidin linkage, 
which was controlled by the optical trap [53]. The biotinylated GPIb-IX was captured 
by another streptavidin bead. This bead was held by a fixed micropipette. It should be 
noted that a small portion of GPIbα and GPIbβ in transfected cells form hmwGPIb 
complexes [166, 176], in addition to the wild-type GPIb-IX (Figure 2.2C). Since 
hmwGPIb is formed in the absence of GPIX [176], specific biotinylation of the GPIX 
cytoplasmic domain ensured that only the native full-length GPIb-IX was immobilized 
to the fixed bead and analyzed here. 
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Figure 2.4 Experimental setup for the optical tweezers single-molecule force 
measurement of the full-length GPIb-IX. The BioTag sequence, that is specifically 
recognized and biotinylated by E. coli biotin ligase, was either appended to the C-
terminus of GPIX cytoplasmic domain (as shown) or placed into the juxtamembrane 
region of the GPIbα cytoplasmic domain. The biotinylated GPIb-IX was expressed in 
transfected cells, solubilized in the Triton X-100-containing lysis buffer, and eventually 
immobilized on the streptavidin-coated bead. Recombinant VWF-A1 was linked 
through a DNA handle to a polystyrene bead that was placed in an optical trap as 
described before [53]. The right bead was held by a fixed micropipette, while the left 
bead was controlled to move by the optical trap. 
In each recorded approach-retract cycle, the trapped VWF-A1 bead was brought 
into contact with the fixed GPIb-IX bead for approximately 1 second at a low contact 
force (~5 pN), and then pulled away. While no or very little (<1 pN) adhesion force 
was observed in ~80% of the approach-retract cycles, a tether that extended to over 200 
nm and ruptured at around 10–30 pN was consistently observed in the other 20% of 
cycles (Figure 2.5A). The force-extension relationship of the tether fitted well with the 
WLC Model [32] in the low force (0–10 pN) regime (Figure 2.5A). It is noteworthy 
that the rupture force of 10–30 pN observed during the retraction step of pulling VWF-
A1 from GPIb-IX was significantly smaller than those observed in the control 
experiment stretching DNA handle-NTA from VWF-A1 (Figure 2.8A), but comparable 
to those reported for the unbinding of VWF-A1 and the GPIbα N-terminal domain 
(Figure 2.6) [114, 156]. Thus, in our optical tweezers experiment we have observed the 
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binding and unbinding of VWF-A1 and full-length GPIb-IX at the single-molecule 
level. 
 
Figure 2.5 Unfolding of a domain by pulling VWF-A1 from biotinylated GPIb-IX. (A) 
A single-molecule force-distance trace illustrating the unfolding of MSD before the 
detachment of VWF-A1 from GPIb-IX. The inset highlights the observed unfolding 
event. (B) Fit of unfolding force vs. extension data to the WLC model (blue dashed 
line), which yielded a contour length of 25.1 ± 0.3 nm. Extension distances were sorted 
by unfolding force into 4-pN bins. A histogram of extension (inset) was used to find 
peak extension. Unfolding forces were averaged for each bin (n per bin is 23–51). Error 
bars are one SD for force and the half bin width for extension. 
In the pulling curves of VWF-A1/GPIb-IX, an extension or unfolding event prior 
to the rupture, with forces ranging from 5 to 20 pN, was observed (Figure 2.5A). The 
WLC fit of the unfolding force and extension yielded a contour length of 25.1 ± 0.3 nm 
(Figure 2.5B), and a persistence length of 0.74 ± 0.04 nm. Assuming a contour length 
of 4 Å per residue, it indicated that a structural domain of approximately 63 residues 
was stretched or unfolded by the pulling force while VWF-A1 was still bound to the 
GPIbα N-terminal domain. Intact domain structures are required for the interaction of 
VWF-A1 with the GPIbα N-terminal domain, both of which contain hundreds of 
residues [154]. Furthermore, similar unfolding events were not observed in either the 
control experiment in which the NTA-DNA handle was pulled from VWF-A1 (Figure 
2.8A) or previous force measurements employing VWF fragments and the GPIbα N-
terminal domain [114, 155, 156]. Therefore, the observed unfolding events in the 
pulling of VWF-A1 from GPIb-IX are not due to unfolding of either of the interacting 
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domains, but rather of a different domain in the GPIb-IX complex, which we designate 
here as the mechanosensitive domain (MSD). 
 
2.3.2 Lifetime of GPIb-IX/VWF-A1 Bonds under Force 
To quantify the pulling of VWF-A1 from biotinylated GPIb-IX, we obtained the 
bonds lifetime of VWF-A1/GPIb-IX by transforming the force histogram according to 
Dudko–Hummer–Szabo equation (Eq. (1.38)) [34]. The bin width is 5 pN, and the force 
is the mean force in each bin (n > 3), and the errors are the SEMs. The plot of lifetimes 
of GPIb-IX/VWF-A1 bond versus force is shown in Figure 2.6. As the external pulling 
force increases, the bond lifetimes become smaller. This plot can be further used as a 
control to demonstrate that we are indeed quantifying the GPIb-IX/VWF-A1 bond(s), 
when compared with results of pulling VWF-A1 from GPIb-IX complex captured by a 
WM23 coated bead. 
 
Figure 2.6 Lifetimes of the GPIb-IX/VWF-A1 bond versus force. The bonds lifetime 
of VWF-A1/GPIb-IX was obtained by transforming the force histogram according to 
Dudko–Hummer–Szabo equation (Eq. (1.38)). The bin width is 5 pN, and the force is 
the mean force in each bin (n > 3), and the errors are the SEMs. The inset is a 
representative histogram of unbinding force (collected under a pulling speed of 100 
nm/s) used to obtain bond lifetimes [34]. 
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2.3.3 Localization of MSD to the Stalk Region of GPIbα 
 
Figure 2.7 Pulling GPIb-IX complex in two other directions. (A) Pulling of DNA 
handle-conjugated WM23 on the GPIbα-biotinylated GPIb-IX complex. (B) Pulling of 
VWF-A1 from GPIb-IX captured on the WM23 bead. 
In order to localize the MSD, we biotinylated and attached the monoclonal antibody 
WM23, which recognizes an epitope in the C-terminal portion of the 
macroglycopeptide region (Figure 1.5) [179], to a fixed bead. We did not observe any 
unfolding events when pulling VWF-A1 from GPIb-IX captured on the WM23 bead, 
while the lifetimes of the GPIb-IX/VWF-A1 bond remained unchanged (Figure 2.8). 
Moreover, a mutant GPIb-IX, in which a juxtamembrane residue in the GPIbα 
cytoplasmic domain was biotinylated, was expressed in HEK293 cells (Figure 2.1A–
B). Pulling of DNA handle-conjugated WM23 on this GPIbα-biotinylated GPIb-IX 
produced similar unfolding events prior to the rupture (Figure 2.8A). Therefore, MSD 
should be located between the WM23 epitope in the macroglycopeptide region and the 
cytoplasmic domain of GPIbα. In other words, it should be in the stalk region or 
transmembrane helix of GPIbα. The force required to unfold a transmembrane helix is 
57 
 
much stronger (>100 pN) [180, 181] than what was observed here (~10 pN). 
Additionally, unfolding of the 25-residue transmembrane helix of GPIbα would have 
produced an unfolding contour length of ~10 nm, much shorter than >20 nm observed 
in the force curves (Figure 2.5). Our results, therefore, suggest that the juxtamembrane 
stalk region of GPIbα contains MSD. 
 
Figure 2.8 Localization of MSD in the juxtamembrane stalk region of GPIbα. (A) 
Overlaid force-distance traces of pulling VWF-A1 on GPIb-IX captured by biotinylated 
WM23 (red trace) and on GPIb-IX captured by biotin at the GPIX cytoplasmic domain 
(grey). (B) Plots of lifetimes of the GPIb-IX/VWF-A1 bond versus force (mean ± SEM, 
n > 3). 
 
2.3.4 Force-Induced Unfolding/Refolding of the Recombinant Stalk Region 
of GPIbα (Ibα-cSc) 
The stalk region of GPIbα has not been studied before, although it has been noted 
for its higher hydrophobic content than the neighboring macroglycopeptide region 
[182]. A recombinant protein Ibα-S that contains the GPIbα stalk region (residues 
Ala417-Phe483) was produced (Figure 2.3). De-convolution of its CD spectrum [183] 
indicated that Ibα-S is a structured domain, with 24% of its residues taking α-helical 
conformation, 19% in β-strand, and the rest in coils. Ibα-S is relatively unstable, as it 
was denatured in less than 1 M urea. Consistently, appending a biotinylated BioTag 
sequence to its C-terminus significantly altered its structure or stability (Figure 2.3). In 
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comparison, a related protein called Ibα-cSc, in which the GPIbα stalk region was 
flanked by a cysteine on each side, displayed a similar CD spectrum as Ibα-S but was 
more stable as judged by urea denaturation. 
Optical tweezers measurement was performed on Ibα-cSc. Each of the flanking 
cysteine residues in Ibα-cSc was linked to a piece of DNA handle and a bead (Figure 
2.9). 
 
Figure 2.9 The optical tweezers setup to measure force-induced unfolding of Ibα-cSc. 
The recombinant Ibα-cSc was coupled with two DNA handles to each of its two 
terminus. One SA bead captured the biotinylated Ibα-cSc handle, and immobilized it 
there. The other bead coated with anti- digoxigenin Fab (abbreviated as “anti-dig bead”) 
was captured and controlled by the optical trap. At each approach-retract cycle, the anti-
dig bead was brought into contact with the fixed SA bead, and was held for a dwell 
time to allow the reaction. 
Upon pulling, Ibα-cSc unfolded at 5–20 pN and was stretched to 10–15 nm (Figure 
2.10A–B), which is comparable to the unfolding force and extension observed in the 
full-length GPIb-IX. WLC fit of the unfolding force as a function of extension yielded 
a contour length of 22.3  1.2 nm and a persistence length of 0.64  0.10 nm. The 
shortening/contraction events during refolding also fell on the same curve (Figure 
2.10B). 
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Figure 2.10 Force-induced unfolding and refolding of Ibα-cSc from pulling 
experiments. (A) Force-distance traces showing the force-induced unfolding and 
refolding of Ibα-cSc from pulling at 100 nm/s. (B) Unfolding force-extension data of 
pulling Ibα-cSc (red squares) fitted to WLC model, yielding a contour length of 22.3  
1.2 nm. Extension distances were sorted by unfolding force into 2-pN bins. A histogram 
of extension of each bin (inset) was fitted to a Gaussian curve (inset, solid line) to find 
peak extension. Unfolding forces were averaged for each bin (n per bin is 43–149 for 
unfolding, and 40–64 for refolding). Error bars are one SD for force and the half width 
of the Gaussian fit for extension. Blue circles represent refolding force-shortening data, 
which was treated in the same way as the unfolding forces-extension. 
To characterize the free-energy landscape, we fit the most probable unfolding force 
as a function of loading rate to the single-barrier Bell–Evans model (shown in Figure 
2.11), which yielded an unfolding rate in the absence of force of 0.008 s-1, and a barrier 
width of 2.6 nm [33]. 
Since Ibα-cSc contains 67 residues between the two cysteine residues, when fully 
stretched it should extend to 26.8 nm, assuming a contour length of 4 Å per residue. 
Thus, our measurement indicated that the end-to-end distance of folded Ibα-cSc is about 
4.5 nm. Overall, these results demonstrated that the GPIbα stalk residues form a 
structured MSD that has a similar unfolding force and extension to that observed in 
GPIb-IX. 
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Figure 2.11 Most probable unfolding force of Ibα-cSc as a function of loading rate. 
Unfolding forces at five different loading rates were plotted as histograms (inset). Each 
histogram was fitted to a Gaussian curve (inset, solid line) to obtain the most probable 
force. Uncertainty in force (the black error bar) is shown as half of the bin width. The 
solid red line is a linear fit of the data to the Bell–Evans model [33]. 
 
2.3.5 Lack of Unfolding in GPIb-IX that Lacks MSD of GPIbα 
To confirm the location of MSD in GPIb-IX, GPIbα mutants that lack the entire 
MSD (GPIbα∆S), the N-terminal (GPIbα∆SN), and C-terminal half (GPIbα∆SC) of the 
domain were constructed (Figure 2.12). Considering the relative instability of MSD, we 
reasoned that deletion of either half of the domain should effectively leave the 
remaining sequence unfolded. Each GPIbα mutant was coexpressed with HA-GPIbβ 
and GPIX-biotag to produce the corresponding mutant GPIb-IX complex in the 
transfected HEK293 cells. Western blot analysis revealed the defective complex 
assembly by GPIbα∆S, as it was present mostly in the hmwGPIb complex [166, 176] 
instead of the native GPIb complex (Figure 2.12B). 
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Figure 2.12 Expression and assembly of the GPIbα mutant complexes. Sequences 
illustrating various deletion mutations in MSD. 
In comparison, both GPIbα∆SN and GPIbα∆SC formed native GPIb, and therefore 
were analyzed further by optical tweezers. VWF-A1 was used in the pulling 
experiments on mutant GPIb-IX complexes containing either GPIbα∆SN or GPIbα∆SC, 
yielding similar bond lifetimes as those observed for the wild-type GPIb-IX (Figure 
2.13A). In contrast to the wild-type, no unfolding events were observed in the pulling 
of either mutant complex (Figure 2.13B). Overall, these results demonstrated that 
disrupting the structure in the GPIbα stalk region eliminates the force-induced 
unfolding event in GPIb-IX, thus confirming the presence of MSD in this region. 
 
Figure 2.13 Lack of force-induced unfolding in GPIb-IX complexes with altered MSD. 
(A) Lifetimes (mean ± SEM of >3 experiments) of the bonds between VWF-A1 and the 
three constructs as a function of force. Each plot is identified by the identity of GPIbα 
subunit in the complex and the pulling ligand. (B) Representative force-distance traces 
of pulling VWF-A1 on GPIbα∆SN/GPIbβ/GPIX (red trace) or GPIbα∆SC/GPIbβ/GPIX 
(blue trace) complex that was captured by biotin at the GPIX cytoplasmic, showing the 
lack of force-induced unfolding. 
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2.4 Discussion and Conclusion 
In this chapter, we present the first evidence for a juxtamembrane MSD in the GPIb-
IX complex. VWF-A1-mediated mechanical pulling on the N-terminal domain of 
GPIbα induced unfolding of a MSD in GPIb-IX (Figure 2.4, Figure 2.5 and Figure 2.6). 
Follow-up studies utilizing different pulling ligands and immobilization sites localized 
MSD to the stalk region of GPIbα (Figure 2.7 and Figure 2.8). Direct characterization 
of the recombinant stalk region revealed that it contains a structured but relatively 
unstable domain and that its sensitivity to tensile force is similar to that of the full-
length complex (Figure 2.9 and Figure 2.10). Finally, disrupting the domain structure 
by deleting a significant portion of the domain eliminated the VWF-A1-induced 
unfolding event in GPIb-IX (Figure 2.13), confirming the location of MSD in the 
juxtamembrane stalk region of GPIbα. Prior to this study, there have been no reports 
about the existence of a structured domain in the stalk region of GPIbα. Little 
information is currently available about this MSD. The CD spectrum of Ibα-S indicates 
the presence of some secondary structure, but it is likely that the conformation of MSD 
in GPIb-IX may be somewhat different from that in recombinant Ibα-S, considering 
that MSD is relatively unstable and sensitive to its surroundings.  
Numerous studies have been carried out to characterize the interaction of VWF or 
its A1 domain with the N-terminal domain of GPIbα, such as the complex structure, the 
binding kinetics, and the influence of force [74, 75, 114, 154–156, 184]. In comparison, 
only a few biophysical studies have focused on the purified GPIb-IX [157, 185], 
primarily due to the difficulty in obtaining this hetero-tetrameric membrane protein 
complex. A previous study has used the optical tweezers to measure the unbinding 
forces between VWF-coated beads and GPIb-IX-expressing Chinese hamster ovary 
cells [186], but it was not conducted under single-molecule experimental conditions 
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and did not report the unfolding event. Here, site-specific biotinylation of the 
cytoplasmic domain enabled a systematic dissection of GPIb-IX under a condition that 
simulated the effect of shear flow on the VWF/GPIb-IX pair. Only through the single-
molecule force measurement on the full-length receptor complex was the MSD in 
GPIb-IX uncovered. This novel setup will be useful in future investigation of GPIb-IX 
structure-function and could be applied to other mechanosensing receptors. Moreover, 
we found that the MSD unfolds at forces ranging from 5 to 20 pN, which is similar to 
the level of forces reported to induce catch- or flex-bond formation in the complex of 
VWF-A1 with the N-terminal domain of GPIbα [114, 155, 156]. The unfolding and 
extension of the MSD could lower the force applied to the VWF/GPIb-IX complex and, 
therefore, may function together with the VWF-A1/GPIbα interaction to stabilize the 
tethering and adhesion of platelets to VWF under flow.  
The identification of a juxtamembrane MSD in GPIb-IX has potential implications 
for the mechanism of platelet mechanosensing. We proposed a model of GPIb-IX 
mechanosensing (naming it “the trigger model”). In this model, the force-induced 
unfolding of MSD is the step in which GPIb-IX converts a mechanical signal into a 
change in protein conformation (Figure 2.14). This type of signal can be recognized 
and transduced further. Under the assumption that platelets behave as spherical beads 
with a radius of 1 µm, it can be estimated that at 20 dynes/cm2, a typical shear stress 
found in the microvasculature, the drag force exerted on a single platelet is 64 pN [187, 
188]. Since it takes only 5–20 pN to unfold MSD in GPIb-IX, it is plausible that VWF, 
under physiological or pathological shear stress, could exert sufficient force on the 
tethered GPIb-IX, and the platelet, to induce the unfolding of MSD therein. Moreover, 
the long and unstructured macroglycopeptide region of GPIbα contains 1–4 copies of 
tandem nucleotide repeat sequence (VNTR), and the VNTR polymorphism contributes 
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to the variation in the molecular weight and length of GPIbα (by as much as 15 nm) 
[189]. The number of VNTR repeat is not correlated with the occurrence of coronary 
heart disease, in which arterial thrombosis and the interaction of VWF/GPIb-IX is 
thought to play an important role [190]. This lack of correlation has not been explained 
in the previously proposed receptor clustering model of GPIb-IX [191], as one would 
expect that the VNTR polymorphism, with its significant impact on GPIbα length, 
should affect the extent of GPIbα clustering on the platelet surface and downstream 
signaling. By comparison, in our model of mechano-transduction the macro-
glycopeptide region is proposed to transduce only the tensile force, which should be 
minimally affected by its length and is therefore consistent with the lack of correlation 
between VNTR polymorphism and occurrence of coronary heart disease. Finally, MSD 
is located in direct contact with the extracellular domains of GPIbβ and GPIX (Figure 
1.5), which can change conformation in response to an alteration in inter-subunit 
contacts [153, 166]. Therefore, we propose that unfolding of MSD induces a 
conformational change in the neighboring GPIbβ and GPIX, which transmits a signal 
into the cell (Figure 2.14). This mechano-transducing model, instead of the receptor 
clustering model, can explain that anti-GPIbβ monoclonal antibody RAM.1 blocks 
VWF-initiated GPIb-IX-mediated signaling into the platelet without affecting VWF 
binding to GPIb-IX [185, 192]. It may also help to explain the critical role of GPIbβ in 
mediating the procoagulant activity of platelets [193]. 
The identification of MSD in GPIb-IX also provides new insights on the 
pathogenesis of BSS. GPIbα is quickly degraded in transfected cells when it is not 
expressed with GPIbβ and GPIX [194]. However, the underlying molecular basis for 
this degradation has remained unclear. It is found that Ibα-S in isolation is not stable 
(Figure 2.3). It is therefore conceivable that the instability of MSD in GPIbα could 
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contribute to the rapid degradation of GPIbα when it is expressed in the absence of 
GPIbβ and GPIX [194]. GPIbβ and GPIX, being close to MSD in the complex, may 
either stabilize the domain or prevent its induction of degradation. Furthermore, the 
potential involvement of GPIbβ and GPIX in detecting unfolding of MSD and further 
propagating the signal offers a plausible functional justification for their elaborative 
complexation with GPIbα. 
 
Figure 2.14 The trigger model of the proposed mechanosensing mechanism of GPIb-
IX. We found in this study that the juxtamembrane MSD in GPIbα is folded, and it 
unfolds upon VWF-mediated pulling. Our results suggest that on the cell surface the 
juxtamembrane MSD in GPIbα is folded in the absence of shear flow (left panel). VWF 
binding under shear to the N-terminal domain of GPIbα induces unfolding of MSD, and 
subsequently a conformational change in the adjacent extracellular domains of GPIbβ 
and GPIX, which sends a signal across the platelet membrane (right). 
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Chapter 3: Development of a Novel Protein Coupling 
Method for Single Molecular Experiments Using Optical 
Tweezers 
3.1 Introduction 
The most single-molecule techniques, including atomic force microscopy (AFM), 
optical tweezers, magnetic tweezers, allow for the direct measurement of individual 
molecular properties. These instruments have a high sensitivity and precision in order 
to manipulate or visualize individual molecules, and measure microscopic forces. 
Depending on the purpose of single-molecule experiments, different systems are set 
up. To measure the mechanical and biological properties of proteins, or protein–protein 
interactions, researchers usually need to create a linkage system with the protein on the 
chain of linkage, and then apply an external force to stretch it using AFM or optical 
tweezers. In these linkage systems, the protein needs to be immobilized at one end, and 
captured on the other end, through some kinds of bindings to beads or substrates. A 
DNA handle is often used in these systems to make the chain softer and longer for better 
measurements. Therefore, there are several connecting points on the single chain, which 
endure the same stretching force as the protein does. These connecting points should 
not break before the conformational change or protein–protein dissociation happens. 
The most widely used techniques involved here are protein tags and disulfide bonds. 
Their features are summarized in Table 3.1. 
The methods of tagging the desired protein with peptides (such as His6, myc, HA, 
and FLAG) or biotin have been widely used by researchers for protein detection, 
purification, and immobilization in single-molecule experiments [102–105]. It is 
known that the affinity between polyhistidine-tag (usually 6×His-tag) and Ni-NTA is 
68 
 
relatively weak and non-covalent, meaning that the binding has low mechanical 
strength and thermodynamic stability, and the reaction is reversible. Furthermore, due 
to the non-specificity of the bonds, the single-molecule experiments usually cannot 
eliminate non-specific interaction between the protein and the polystyrene bead in a 
single-molecule system. The disulfide bonds are strong, but this method needs protein 
reduction step, which also has an effect on proteins’ internal disulfide bonds, and further 
changes their native structures and properties. However, in single-molecule force 
experiments, statistical analysis of events, e.g. unfolding/refolding and rupture, are 
necessary for drawing convincible conclusions. It requires the linkage system to be 
stable, and it would best that one can repeatedly pull the same tether for many times. It 
has been difficult to achieve a mechanically stable system for single-molecule pulling 
experiments using these traditional methods. 
Table 3.1 Comparison of different linking methods in single-molecule systems 
Recently, Mark Howarth et al. [36] proposed a new tagging method through the 
formation of a rapid covalent bond without using chemical modification, artificial 
amino acids, or cysteines. They obtained a peptide tag of 13 amino acids (termed 
SpyTag) by splitting the Streptococcus pyogenes (S. pyogenes) CnaB2 domain. SpyTag 
is capable of forming a covalent bond with its partner SpyCatcher, a rational 
modification of the rest protein fragments from the splitting of CnaB2, as shown in 
Figure 1.8. This reaction proceeds spontaneously, rapidly, efficiently throughout 
diverse conditions of buffer, pH, and temperature. Moreover, the SpyTag/SpyCatcher 
Linkages Mechanical Stability 
Disulfide Bonds Strong, needs reduction before coupling 
Polyhistidine-tag–Ni-NTA Weak 
Biotin–Avidin/Streptavidin Strong, needs biotinylation 
Antibody–Antigen Intermediate 
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bonds have a high mechanical stability with a lifetime of more than one day, and a high 
mechanical strength of 131 pN [36]. The specific binding between SpyTag and 
SpyCatcher allows potential simplification of single-molecule force spectroscopy 
experiments. 
In this chapter, I will demonstrate the development of a novel method by forming 
an unbreakable site-specific linkage with the application of the SpyTag/SpyCatcher 
bonds. The new system is very effective for single molecular experiments using optical 
tweezers. I will demonstrate the advantages, such as high mechanical stability and 
strength, high efficiency, and simplification by eliminating sample purification step. In 
Chapter 4, I will also provide an approach for measuring the domain-domain 
interactions in complexed proteins with abundant inner disulfide bonds, such as VWF, 
using the SpyTag system. 
 
3.2 Materials and Methods 
3.2.1 Materials 
Synthetic SpyTag with C-terminal Cysteine (AHIVMVDAYKPTKGGC) and N-
terminal Cysteine (CGGAHIVMVDAYKPTK) were purchased from Genscript 
(Piscataway, NJ). SpyCatcher, SpyCatcher EQ, and MPB-SpyTag were kindly 
provided by Mark Howarth’s group at the University of Oxford. SpyCatcher EQ is a 
mutation of the catalytic Glu77 that prohibits isopeptide bond formation, and MPB-
SpyTag is a fusion protein of MPB and SpyTag. 
The proteins were first cloned in pDEST14 vector and were expressed using E. coli 
BL21 DE3 pLysS cells (Stratagene), while constructs cloned in pET28a were expressed 
using E. coli BL21 DE3 RIPL cells (Stratagene). Cultures were grown overnight in LB 
containing 0.1 mg/mL ampicillin and 0.034 mg/mL chloramphenicol (pDEST14) or 0.5 
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mg/mL kanamycin (pET28a). Overnight cultures were diluted 100-fold and grown at 
37 °C to A600 0.5, then induced with 0.4 mM IPTG and grown at 30 °C for 4 h. 
Nickel affinity chromatography following standard techniques was used to purify 
all proteins, except for SpyTag-MBP, which was purified using amylose-agarose (New 
England Biolabs) with 10 mM maltose elution. For MBP-SpyTag-Zif-SpyTag, binding 
buffer for the amylose agarose contained 600 mM NaCl to improve purity. After elution 
from the columns, proteins were dialyzed three times into PBS. Protein concentrations 
were determined using the Micro Bicinchoninic Acid (BCA) Assay kit (Thermo 
Scientific), following manufacturer’s instructions. 
 
3.2.2 Expression and Purification of SpyTag-α4β7 Integrin 
Recombinant Spy-tagged integrin constructs were constructed in the pHLsec vector. 
All cDNAs were cloned into the Age I and Xho I sites of the plasmid, which encodes 
an N-terminal secretion signal sequence and a C-terminal His6 tag. Plasmids of α4, β7, 
and a biotinlygase A (provided by Mark Horwarth in Oxford) were co-transfected to 
HEK293T cells using MegaTran reagent (Origine). Culture supernatants were 
harvested after 5 days of transfection and proteins were purified using Ni-NTA affinity 
chromatography followed by size-exclusion chromatography [195]. 
 
3.2.3 Laser Optical Tweezers Measurement 
Carboxyl-polystyrene beads of 2.0-μm diameter (Spherotech, Lake Forest, IL) were 
covalently coupled with streptavidin (Invitrogen) as described previously [53, 114]. 
SpyCatcher or SpyCatcher EQ was coupled with biotin-DNA handle (at 4 : 1 ratio) at 
room temperature (25 °C) for overnight first. To measure the mechanical stability and 
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strength of the SpyTag/SpyCatcher bonds, streptavidin-coated (SA) beads were 
incubated with C-terminal/N-terminal SpyTag for 10 min in Tris-buffered saline (150 
mM NaCl, 10 mM Tris·HCl, pH 7.5) at 25 °C to couple the SpyTag. SpyCatcher and 
SpyCatcher EQ, with biotin-DNA handle, were then coupled to SA beads in a similar 
way, respectively. To further test the efficiency of SpyTag system, SpyTag was fused 
to maltose-binding protein (SpyTag-MBP). To apply the novel tagging method, we 
selected the complexed protein, integrin α4β7. SpyTag-α4β7 was prepared by fusing 
SpyTag to integrin α4β7 on its N-terminal end (Section 3.2.2). Before the optical 
tweezers experiments, SpyTag-MBP, purified SpyTag-α4β7, or non-purified SpyTag-
α4β7 supernatant was incubated with SA beads to immobilize the construct on the bead’s 
surface. SpyCatcher with DNA handle was mixed with SA beads. Single-molecule 
pulling experiments were performed using an analytical mini-optical tweezers 
apparatus. One bead with one type of construct was fixed by the micropipette, while 
the other bead with the other type of construct was controlled by the optical trap. The 
single-molecule measurement was performed in the force-ramp mode, where the 
applied force increases linearly with the pulling distance. The pulling speeds were 
typically set to 50 nm/s, 100 nm/s, 150 nm/s, 200 nm/s, and 300 nm/s. The survival 
frequency, indicating the bonds stability, is calculated as the fraction of the binding 
events with a lifetime longer than a certain value t (seconds). To characterize the bio-
mechanical properties of the protein, WLC model [32] is used to fit the force-extension 
data. 
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3.3 Results 
3.3.1 Lifetime of the SpyTag/SpyCatcher Covalent Bonds 
To quantify the mechanical stability and mechanical strength of the 
SpyTag/SpyCatcher covalent bonds, we decided to measure and plot the survival 
frequency versus the bond lifetime using mini-optical tweezers. Bond lifetimes were 
measured from the start of holding at a high force (~65 pN) to until the bond ruptured. 
Survival frequency is calculated as the fraction of the binding events with a lifetime 
longer than a certain value t, which is 
where fi is the survival frequency at the corresponding bond lifetime ti, nt≥ti is the count 
of events with bond lifetimes that are greater than ti, and N is the total number of events. 
Assuming the bond dissociation occurs from a single bond state, the bond survival 
probability can be described by a single exponential function 
where koff is the intrinsic off rate of the bond. Eq. (3.2) also predicts that the logarithm 
of the bond survival probability is linearly correlated with the bond lifetime. Least 
squares fitting of the bond survival frequency to the bond lifetime gives an estimate of 
the intrinsic off rate, which is an indication of the bonds stability. 
During an approach-retract cycle of the single-molecule pulling experiment, one 
trapped SA bead coupled with either C-SpyTag or N-SpyTag was brought into contact 
with another fixed SA bead, coupled with SpyCatcher (EQ) biotin-DNA handle, for a 
constant dwell time (~10 s) at low contact force (~5 pN), and then pulled away. Once a 
tether was successfully picked up, we tried to hold the trapped bead at a constant force 
 1i i
t t t t
i
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N N
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    (3.1) 
 exp( )i off if k t   (3.2) 
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around DNA overstretching (~65 pN), and recorded the lifetime of the binding (Figure 
3.1). 
 
Figure 3.1 The optical tweezers setup to measure the mechanical properties of the 
SpyTag/SpyCatcher bonds. C-terminal/N-terminal SpyTag, SpyCatcher, and 
SpyCatcher EQ were used in the optical tweezers pulling experiments. During an 
approach-retract cycle of the single-molecule pulling experiment, one trapped SA bead 
coupled with either C-SpyTag or N-SpyTag was brought into contact with another fixed 
SA bead, which was coupled with SpyCatcher or SpyCatcher (EQ) biotin-DNA handle 
for a constant dwell time (~10 s) at a low contact force (~5 pN), and then pulled away. 
Once a tether was successfully picked up, we held the trapped bead at a constant force 
around DNA overstretching (~65 pN), and recorded the lifetime of the binding. 
The plots of semi-log survival frequency versus lifetime for C-/N- 
SpyTag/SpyCatcher (or SpyCatcher EQ) are shown in Figure 3.2. Least squares fitting 
to the data from C-SpyTag/SpyCatcher EQ (red triangle) and N-SpyTag/SpyCatcher 
EQ (purple triangle) yielded 
Neither C-SpyTag nor N-SpyTag formed any covalent bond with the mutant, 
SpyCatcher EQ, which was in good agreement with ref. [36]. For the interaction 
between C-SpyTag or N-SpyTag and SpyCatcher, the semi-log lifetime distributions 
appear as two line segments connected at ~100 s. It can be explained that the covalent 
bonds were formed for the segment where the lifetimes are more than ~100 s, while 
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they were not formed in the other segment. Least squares fitting to the data of long-
lifetime segments yielded 
(i) When the non-covalent bonds formed (with fitting results shown as blue and 
green dashed lines in Figure 3.2): 
These dissociation rates are similar to these in Eq. (3.3) indicating that the 
SpyTag/SpyCatcher covalent bonds were not formed for these data points. 
(ii) When the covalent bonds formed (with fitting results shown as blue and 
green lines in Figure 3.2): 
We compared the bond lifetimes calculated by using the reciprocal of dissociation 
rates in Eq. (3.5) and Eq. (3.3), found that when the lifetimes of the covalent 
SpyTag/SpyCatcher bonds are approximately 100 to 150 times longer than that of the 
non-covalent bonds between SpyTag and SpyCatcher EQ. Furthermore, there is 
minimal difference in the covalent bonds lifetimes of C-SpyTag/SpyCatcher and N-
SpyTag/SpyCatcher. It means that when fusing a desired protein with SpyTag, we can 
add SpyTag to either of its termini without sacrificing the covalent bond stability. This 
makes the single-molecule experiments simpler. 
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Figure 3.2 Semi-log survival frequency versus lifetime of SpyTag/SpyCatcher and 
SpyTag/SpyCatcher EQ bonds. Survival frequency is calculated as the fraction of the 
binding events with a lifetime longer than a certain value 𝑡. Assuming that the bond 
dissociation occurs from a single bond state, the logarithm of the bond survival 
probability is linearly correlated with the bond lifetime. Least squares fitting to the data 
of C-SpyTag/SpyCatcher EQ (red triangle) and N-SpyTag/SpyCatcher EQ (purple 
triangle) gives the intrinsic dissociation rate of 0.047 ± 0.005 s-1 and 0.124 ± 0.008 s-1, 
respectively. For the interaction between C- or N-SpyTag and SpyCatcher, the 
distributions appears as two line segments connected at ~100 s. Fitting the two segments 
of longer lifetimes when the covalent bonds form, gives dissociation rates of (8.52 ± 
1.32)×10-4 s-1 and 0.033 ± 0.006 s-1 for C-SpyTag/SpyCatcher, and (1.19 ± 0.24)×10-3 
s-1 and 0.029 ± 0.003 s-1 for N-SpyTag/SpyCatcher, respectively. The lifetimes of the 
covalent SpyTag/SpyCatcher bonds are approximately 100 to 150 times longer than 
that of the non-covalent bonds between SpyTag and SpyCatcher EQ. Furthermore, there 
is minimal difference in the covalent bonds lifetimes of C-SpyTag/SpyCatcher and N-
SpyTag/SpyCatcher. 
We also plotted the force versus time from pulling SpyTag/SpyCatcher experiments 
(Figure 3.3). During each approach-retract cycle, one bead controlled by the optical trap 
approached the other fixed bead (shown as the blue trace), and was held to contact with 
each other for ~10 seconds of dwell time to allow the formation of SpyTag/SpyCatcher 
covalent bond. Once the covalent bond formed, the bead was pulled away and the force 
applied on this system increased gradually over time (red trace). When we saw the DNA 
overstretching ~65 pN, we held the bead to sustain at that force utilizing optical 
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tweezers’ feedback system. During each pulling, we held the bonds at the same external 
preset force until they broke, then we could measure the lifetime from the plot directly. 
We found that the covalent bonds of SpyTag/SpyCatcher were stable to hold for as long 
as 1.4 h (Figure 3.3). 
Therefore, our single-molecule experiment of pulling SpyTag/SpyCatcher and 
SpyTag/SpyCatcher EQ demonstrated that this novel system has remarkable 
advantages on mechanical stability and mechanical strength once the covalent bonds 
form. 
 
Figure 3.3 Mechanical strength of the SpyTag/SpyCatcher bonds. During each 
approach-retract cycle, one bead controlled by the optical trap approached the other 
fixed bead (blue trace), and was held to contact with each other for ~10 seconds of 
dwell time to form SpyTag/SpyCatcher covalent bonds. The bead was pulled away and 
the force applied on this system increased gradually over time (red trace). At the DNA 
overstretching ~65 pN, the bead was held to sustain at that force utilizing optical 
tweezers’ feedback system. The covalent bonds of SpyTag/SpyCatcher were stable 
enough that the lifetime could be as long as 1.4 h. 
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3.3.2 Repeated Maltose-Binding Protein (MPB) Unfoldings with SpyTag 
The first application of the novel SpyTag system is optical tweezers single-molecule 
force spectroscopy of the maltose-binding protein (MPB), which has already been well 
studied using different methods [36, 196–204]. In this application, we intended to 
demonstrate the prominent stability and efficiency of the new SpyTag system. SpyTag-
MBP and SpyCatcher were expressed in E. coli and purified using Ni-NTA resin. 
SpyTag-MBP was incubated with SA beads—prepared as described previously—in 
Tris-buffered saline (150 mM NaCl, 10 mM Tris·HCl, pH 7.5) at 25 °C for 10 min. 
SpyCatcher was coupled with biotinylated DNA handle first, and then incubated with 
SA beads at the same condition. Before a good tether was picked up, one SpyTag-MPB-
coupled bead was brought into contact with another fixed SpyCatcher-coupled bead for 
a constant dwell time (~2 s) at a low contact force (~5 pN) and then pulled away in each 
approach-retract cycle. After picking up a good tether, we did not allow the two beads 
to contact each other to eliminate further undesired bindings between other proteins. To 
realize that, we set a minimum force (above zero) to trigger the bead to retract before 
touching the other one. The tether is good when some unfolding events happen at ~30 
pN, and can be further stretched to reach DNA overstretching, indicating that the 
covalent SpyTag/SpyCatcher bond is likely to be formed. 
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Figure 3.4 The optical tweezers setup to measure force-induced unfolding of MBP 
using the SpyTag system. MBP was fused with SpyTag to form SpyTag-MBP, 
incubated with SA beads for 10 min in Tris-buffered saline (150 mM NaCl, 10 mM 
Tris·HCl, pH 7.5) at 25 °C. SpyCatcher was coupled with biotinylated DNA handle 
first, and then incubated with SA beads for 10 min at the same condition. Before a good 
tether was picked up, one SpyTag-MPB-coupled bead was brought into contact with 
another fixed SpyCatcher-coupled bead, for a constant dwell time (~2 s) at a low contact 
force (~5 pN), and then pulled away in each approach-retract cycle. 
Figure 3.5 shows 65 overlaid retract force-extension curves (approach force-
extension curves are not shown here) from the pulling of a single tether at a pulling 
speed of 500 nm/s. The efficiency of the stable SpyTag system allows for acquiring a 
good histogram of the unfolding force or extension by performing the single-molecule 
experiments on one tether in one time. The unfolding force varied from ~10 pN to 50 
pN, while the unfolding extension varied from ~40 nm to ~80 nm. 
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Figure 3.5 Overlaid force-extension curves of pulling MPB. 65 retract force-extension 
curves (approach force-extension curves are not shown here) from the pulling of one 
single SpyTag-MBP tether were overlapped together. The pulling speed is 500 nm/s. 
The efficiency of the stable SpyTag system allows for acquiring a good histogram of 
unfolding forces/extension by performing single-molecule experiments on one tether in 
one time. The unfolding force varied from ~10 pN to 50 pN, while the unfolding 
extension varied from ~40 nm to ~80 nm. The curves showed an intermediate state of 
MBP unfolding, as well as the normal native folded state and unfolded state. 
To extract mechanical properties from these unfolding forces and extensions, a 
widely used statistical approach [53, 114, 205, 206] was employed. MBP force-
extension data is shown in Figure 3.6. Unfolding extension was sorted by unfolding 
force into 5-pN bins. A histogram of extensions for each bin (inset) was fitted to 
Gaussian distribution (inset, solid line) to find the most probable extension, and the 
corresponding force was the mean value for forces within that bin (n per bin is 10 to 
47). Error bars are the SEM for force and one SD for extension. The processed force-
extension points were then fitted to the worm-like chain (WLC) model by error-
weighted least squares [31, 207]. The WLC fit yielded a contour length of Lc = 93.8 ± 
1.2 nm and a persistence length of Lp = 0.85 ± 0.10 nm. These results are in good 
agreement with previous work [200]. Moreover, when reconsidering the force-
extension data shown in Figure 3.5, we found that there is an intermediate state of MBP, 
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other than the native folded state and the activated unfolded state. The intermediate 
state occurrs at a lower force (~25 pN) than the initial unfolding force. It is suggested 
that a further and more careful analysis of the contour length and the persistence length 
needs to be performed based on multiple peaks of the extension distribution, instead of 
considering it with merely one peak. In fact, the intermediate state of MBP unfolding 
has been reported in recent work [197, 199], and our fitted parameters are comparable 
with the published parameters. 
  
Figure 3.6 MBP force-extension data with an error weighted least squares fit to the 
WLC model. Unfolding extension was sorted by unfolding force into 5-pN bins. A 
histogram of extensions for each bin (inset) was fitted to Gaussian distribution (inset, 
solid line) to find the most probable extension, and the corresponding force was the 
mean value for forces within that bin (n per bin is 10 to 47). Error bars are the SEM for 
force and one SD for extension. The processed force-extension points were then fitted 
to the WLC model (black line) by error-weighted least squares [31, 207], and yielded a 
contour length of 93.8 ± 1.2 nm and a persistence length of 0.85 ± 0.10 nm. 
Therefore, the first application of the newly developed SpyTag system on single 
maltose-binding protein (MBP) optical tweezers experiments has demonstrated its 
unprecedented advantage of experimental efficiency, i.e., with only one good tether 
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picked up, the system is capable of sustaining at a stable condition and observing a 
number of protein conformational events, such as unfolding or refolding. 
 
3.3.3 Purification-Free Single-Molecule Pulling of a Complexed Protein: 
Integrin α4β7 
As descripted earlier at the beginning (in Section 1.3 and 3.1), the peptide SpyTag 
forms an amide covalent bond spontaneously with its protein partner, SpyCatcher. The 
reaction happens simply after they are mixed together, despite of diverse conditions of 
pH, temperature, and buffer [36]. Since SpyTag binds to SpyCatcher bonds specifically, 
we aimed to use this property to simply single-molecule force spectroscopy 
experiments. If we fuse the SpyTag gene sequence to the desired protein, e.g., von 
Willebrand factor (VWF) or integrin, and make it to be appropriately expressed, then 
we should be able to grab the protein fusion using SpyCatcher, thereby eliminating the 
protein purification step before single molecular experiments. Inspired by this idea, we 
performed the single molecular optical tweezers experiments on integrin α4β7, a kind of 
complexed protein (Figure 1.7). 
We performed the single-molecule pulling experiments of integrin α4β7 with the 
new SpyTag system. In the first part, purified SpyTag-α4β7 fusion was incubated with 
10 times diluted SA beads, prepared as described previously, for 10 min in Tris-
buffered saline (150 mM NaCl, 10 mM Tris·HCl, pH 7.5) at 25 °C. SpyCatcher was 
coupled with biotinylated DNA handle and then incubated with SA beads at the same 
condition. We used two different kinds of reaction buffer. One was the Tris-buffered 
saline with 1 mM Ca2+ and 1 mM Mg2+, the other one was the Tris-buffered saline with 
no Ca2+ and 2 mM Mg2+ for the control experiment. 0.05% Tween 20 was used in both 
situations. During an approach-retract cycle, one SA bead coupled with SpyTag-α4β7 
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was brought into contact with another fixed SpyCatcher-coupled bead for a constant 
dwell time (~2 s) at a low contact force (~5 pN), and then pulled away at a constant 
velocity (~200 nm/s). After a good tether was picked up, we set up a movement 
boundary for the optical trap to prevent the two beads from contacting each other again. 
Before contacting each other, the trapped bead retracted away. This action aimed to 
eliminating unnecessary bindings/interactions between molecules, since we hoped it to 
be at a single molecular level. We had no information about what would happen when 
some external force was applied on α4β7, but we expected to see conformational 
changes or unfolding events when stretching it. We tried to repeat for more cycles when 
observing a DNA overstretching pattern from the pulling of a tether. If we did not 
observed any conformational change for many cycles, then we flushed away the two 
beads, and captured another two to repeat the experiments. 
It is reported that there are about 1 mM Ca2+ and 1 mM Mg2+ and in blood and the 
existence of Ca2+ plays an important role in keeping integrins in an inactive state [208]. 
Therefore, in the single-molecule pulling experiments using Tris buffer with 1 mM Ca2+ 
and 1 mM Mg2+, we expected to see the conformational changes of integrin α4β7 from 
its inactive state to the active state under the stretched force, while in the control group 
using Tris buffer with only 2 mM Ca2+, we expected to see no conformational change 
since it is in an extended activated state. 
As expected, we observed a conformational change when pulling purified integrin 
α4β7 (shown in Figure 3.7A). The red curves demonstrated that the conformational 
change occurring at a force of ~6 pN, and the protein’s structure changed gradually to 
stretching force, instead of a sharp decrease of force seen in unfolding events. This 
phenomena could result from breaking the interactions between two legs of native α4β7. 
The novel SpyTag system still showed its mechanical stability and strength. 
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Figure 3.7 Single-molecule pulling of integrin α4β7 with Ca2+. (A) Overlaid retraction 
curves of pulling purified integrin α4β7 in the single-molecule experiments. The buffer 
was Tris-buffered saline (150 mM NaCl, 10 mM Tris·HCl, pH 7.5) with 1 mM Ca2+ 
and 1 mM Mg2+. A conformational change occurring at ~6 pN was observed. (B) 
Overlaid retraction curves of pulling integrin α4β7 using its supernatant in the single-
molecule experiments. The buffer was same as used in (A). A similar conformational 
change occurring at ~6 pN was observed. 
In the second part, SpyTag-α4β7 fusion was successfully expressed, but not purified. 
Similar to the sample preparations procedure described above, we incubated the 
SpyCatcher bio-handle with SA beads (diluted 10 fold). However, we incubated SA 
beads (diluted 10 fold) with SpyTag-α4β7 fusion supernatant. It is not feasible to employ 
traditional tagging methods since the single-molecule measurement is not guaranteed. 
This time, we observed that a similar conformational change happened as that 
overserved when pulling purified integrin α4β7 (shown in Figure 3.7B). The 
conformational change started at a similar force of ~6 pN, and no sharp unfolding 
events were observed. This phenomena again could arise from the breaking of the 
interactions between two legs of native α4β7 integrin. 
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Figure 3.8 Single-molecule pulling of integrin α4β7 without Ca2+. Typical force-
extension curves of pulling purified integrin α4β7 in Tris buffer with 2 mM Mg2+ and 
no Ca2+. The red line and blue line represent the retract process and approach process, 
respectively. DNA overstretching at ~65 pN was observed, and no conformational 
change of α4β7 was seen. 
Figure 3.8 shows typical force-extension curves from the pulling of purified integrin 
α4β7 in Tris buffer with 2 mM Mg2+ and no Ca2+. In the control experiment, DNA 
overstretching at ~65 pN was observed, and no conformational change of α4β7 was seen, 
which agrees well with the fact that Ca2+ is required to keep integrins in an inactive 
state. 
In order to precisely characterize the conformational change of integrin α4β7 under 
force load, more single-molecule experiments need to be carried out to help make a 
more convincible conclusion. However, the application of the new SpyTag system did 
show its advantage over traditional systems by eliminating the sample purification step, 
as well as providing a new approach to investigate complexed proteins, such as integrin 
α4β7. 
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3.4 Discussion and Conclusion 
In this chapter, we intended to apply the SpyTag/SpyCatcher covalent bonds to 
develop an unbreakable site-specific linkage for single-molecule force measurements, 
especially for use with optical tweezers. 
The new SpyTag system ensures high mechanical stability and mechanical strength. 
We found that the lifetimes of formed covalent SpyTag/SpyCatcher bonds are 
approximately 100 to 150 times longer than that of the non-covalent bonds between 
SpyTag and SpyCatcher EQ, and the covalent bonds of SpyTag/SpyCatcher are so 
stable that they can be held at a high force (~65 pN) for as long as 1.4 h. Furthermore, 
there is minimal difference in the lifetimes of C-SpyTag/SpyCatcher and N-
SpyTag/SpyCatcher. This makes the single molecular experiments simpler, since we 
can fuse SpyTag to desired samples on either of its termini without sacrificing the 
covalent bonds stability. 
We demonstrated the unprecedented advantages of experimental efficiency by 
applying the novel SpyTag system in single-molecule force experiments of pulling 
MBP. A good histogram of unfolding forces/extensions with 65 events, necessary for 
further data analysis, was directly obtained from the pulling of one tether at a pulling 
speed of 500 nm/s in one time. The fitted parameters, including the contour length and 
persistence length of MBP, agree well with published results [200]. We also observed 
an intermediate state of MBP. When necessary, we can further fit the force-loading rate 
data to the Bell–Evans model [33] and Dudko model [34], to extract the two-state free-
energy landscape, including the spontaneous unfolding rate, the barrier width, and the 
barrier height. 
The new SpyTag system showed that it can simplify the single-molecule 
experiments by eliminating the sample purification step, as well as providing a new 
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approach to investigate complexed proteins, such as integrin α4β7. We observed, for the 
first time, the conformational change from the pulling of both purified integrin α4β7 and 
non-purified integrin α4β7, in the existence of Ca2+ (Figure 3.7). The conformational 
change both started at a small force of ~6 pN, and no sharp unfolding events were 
observed. This phenomena could come from the breaking of the interactions between 
two legs of native integrin α4β7. Also, the control experiment showed no conformational 
change of pulling integrin α4β7 in the absence of Ca2+. However, in order to precisely 
characterize the conformational change of integrin α4β7 under the external force, more 
single-molecule experiments need to be performed to help to make a more reliable 
conclusion. 
The novel SpyTag system does not involve any protein reduction procedure, which 
makes it promising for measuring protein’s domain-domain interactions, such as von 
Willebrand factor (VWF). This type of protein have disulfide bonds inside its internal 
structure, so the reduction reaction, required by some traditional single-molecule force 
spectroscopy methods, will also destroy the disulfide bonds and thus alter the structure 
and properties of the protein. In next chapter, I will show the study of VWF 
conformational change with/without the existence of factor VIII (FVIII), as well as new 
application of this novel SpyTag system. 
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Chapter 4: Exploring the Influence of FVIII in VWF 
Unfolding/Folding Process 
4.1 Introduction 
In physiologic hemostasis and pathologic thrombosis, the enhanced mechanical 
shear force generated by blood flow at the bleeding site triggers the activation of von 
Willebrand factor (VWF) multimers. The VWF multimers mediate the platelet 
adhesion to collagen by acting as an intermediary between collagen fibrils on damaged 
blood vessel walls and platelets in blood. Platelet aggregation, which is induced by the 
enhanced shear stress, requires the existence of VWF and its platelet surface receptor 
glycoprotein (GP) Ib-IX and integrin αIIbβ3 (GPIIb/IIIa) [50, 51]. The Springer group 
[53] discovered the mechanism of mechanoenzymatic cleavage of the ultralarge 
vascular protein VWF. The VWF multimers react to elongational forces and unfolds 
their A2 domains for cleavage by ADAMTS13. Recently Zhang et al. [58, 209] 
identified a juxtamembrane mechanosensitive domain in glycoprotein (GP) Ib-IX 
complex, the platelet receptor of VWF. It then proposed a trigger model where VWF-
mediated pulling under fluid shear induces unfolding of the mechanosensory domain in 
GPIb-IX, and subsequently a conformational change in the adjacent extracellular 
domains of GPIbβ and GPIX occurs which sends in a signal across the platelet 
membrane to stimulate platelets [209]. 
One important VWF function is to serve as a carrier protein of human clotting factor 
VIII (FVIII) or antihemophilic factor [210]. FVIII has long been reported to have two 
distinct biological functions—coagulant activity and a role in primary hemostasis [49]. 
The native conformation of the D’ domain of VWF (Figure 1.3) is required for both 
FVIII binding and normal multimerization and optimal secretion [211]. It is required to 
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form a noncovalent complex with VWF for the normal survival of FVIII in the blood 
circulation [212, 213]. The light chain of FVIII contains two distinct domains that 
associate with VWF. One domain is an acidic cluster in the amino terminus of A3 
domain [214–217], and the other is the C2 domain [218, 219]. The C2 domain is 
comprised of the carboxy-terminal 159 amino acids and contains essential binding sites 
for VWF and is responsible for binding to platelet membrane surfaces [82, 87]. 
However, how FVIII binds to VWF and affects its function has remained elusive. 
In this Chapter, I will show the single-molecule experiments on VWF fragments 
using optical tweezers and atomic force microscopy (AFM). The VWF fragments we 
investigated include D’-D3, D’-D3-A1, D’-D3-A1-A2, and A2 alone. In this way, we 
expected to see the domain-domain interactions within VWF. Meanwhile, we added 
FVIII to incubate with the fragments, so that we can explore the influence of FVIII in 
VWF unfolding/folding process. And also, since the traditional linking methods will 
break these inner disulfide bonds between VWF domains in the sample reduction step, 
we applied the newly developed SpyTag system (described in Chapter 3) to overcome 
this problem. 
  
4.2 Materials and Methods 
4.2.1 Materials 
Synthetic SpyTag with C-terminal Cysteine (AHIVMVDAYKPTKGGC) or N-
terminal Cysteine (CGGAHIVMVDAYKPTK) was purchased from Genscript 
(Piscataway, NJ). D’D3-SpyTag, D’D3A1-SpyTag, D’D3A1A2-SpyTag, and factor 
VIII (FVIII) were produced and kindly provided by Dr. X. Long Zheng at the 
University of Alabama at Birmingham. SpyCatcher was produced and kindly provided 
by Mark Howarth’s group at the University of Oxford. 
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4.2.2 Expression of VWF A2 
The cDNA of human VWF A2 domain (Pro1480 to Pro1678 with prepro-VWF 
numbering) was PCR-amplified with or without additional cysteines flanking the N and 
C termini added using PCR primers. All cDNAs were cloned into the Age I and Xho I 
sites of plasmid pHLsec [220], which encodes an N-terminal secretion signal sequence 
and a C-terminal His6 tag. Plasmids were transfected to HEK293T cells using 
lipofectamine reagent (Invitrogen). Culture supernatants were harvested after 5 days of 
transfection and proteins were purified using Ni-NTA affinity chromatography 
followed by size-exclusion chromatography in 155 mM NaCl, 3 mM Na2HPO4, 1 mM 
KH2PO4 (PBS). 
 
4.2.3 Coating of the Probes and Substrate 
Factor VIII was coated to the cantilever, and D’D3A1A2 was coated to the dish 
surface. The detailed protocol of using gas-phase amino-silanization to coat the AFM 
cantilever and the dish is from http://www.jku.at/biophysics/content/e257042. The 
AFM probes used are soft Silicon Nitride cantilevers with Silicon Nitride tips (Bruker 
Nano Inc., model MLCT-UT). The dish used to coat VWF fragment is the common 
microscopy glass slide (75 × 25 × 1 mm). 
 
4.2.4 Laser Optical Tweezers Measurement 
Carboxyl-polystyrene beads of 2.0-μm diameter (Spherotech, Lake Forest, IL) were 
covalently coupled with streptavidin (Invitrogen) as described previously [53, 114]. 
SpyCatcher was coupled with biotin-DNA handle before the experiments. 
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For measuring the domain-domain interactions of VWF fragments, we performed 
the single-molecule experiments using optical tweezers. In preparation, streptavidin-
coated (SA) beads were incubated with C-terminal/N-terminal SpyTag for 10 min in 
Tris-buffered saline (150 mM NaCl, 10 mM Tris·HCl, pH 7.5) at 25 °C to couple one 
kind of Spy-tagged VWF fragment. SpyCatcher was first coupled biotin-DNA handle, 
and then incubated with SA beads in a similar way. During the pulling experiments of 
each kind of VWF fragment, one SA bead with SpyCatcher-DNA handle on its surface 
was fixed by the micropipette, while another bead coupled with that kind of VWF 
fragment was trapped and controlled by the optical tweezers. The force measurement 
was performed in the force-ramp mode, where the stretching force increases linearly 
with the pulling distance. The pulling speeds were usually set to be 50 nm/s, 100 nm/s, 
150 nm/s, 200 nm/s, and 300 nm/s. After observing interactions between the VWF 
domains, we added 5 nM FVIII to the reaction chamber and repeated the pulling 
experiments. 
For the VWF A2 domain, we performed the single-molecule experiment using 
purified Spy-tagged A2 and Spy-tagged A2 supernatant. Meanwhile, we used A2-DNA 
handle, immobilized to two beads coated with streptavidin and anti-digoxigenin 
antibody, respectively. 
When appropriate, the force-extension data (if there is some unfolding or 
conformational change) would be fitted to WLC model [32] to characterize its 
mechanical properties, and force-loading rate data would be fitted to the Bell–Evans 
model [33] or Dudko model [34] to depict the two-state free-energy landscape. 
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4.2.5 Atomic Force Microscopy (AFM) Force Measurement 
To measure the interaction between FVIII and VWF D’-D3-A1-A2 fragment, I used 
a home-built atomic force microscopy (AFM) instrument (Figure 1.14), since the 
applied force from optical tweezers is too high for it to reach (~70 to 160 pN). The 
cantilever was coated with FVIII, while the dish substrate surface was coated with the 
VWF fragment, D’D3A1A2. The holder where the cantilever is fixed was controlled 
by the piezoelectric actuator. In one approach-retract cycle, the piezoelectric actuator 
brought the holder down to approach and pressed the coverslip’s surface. By setting a 
trigger signal, the piezo state would stop to avoid damaging the cantilever. We also set 
a dwell time to allow longer interaction between the constructs (usually 1 s to 5 s). It is 
noticed that the part of the fragment that was picked up by the tip is random. Then the 
cantilever moved upward to retract within a distance of Z range. Five different pulling 
speeds with a reasonable range were performed to get five different force loading rates. 
The unbinding force-loading rate data was fitted to the Bell–Evans model [33] or Dudko 
model [34] to quantify the interactions. 
 
4.3 Results 
4.3.1 Pulling of D’D3 without FVIII 
To measure the most simple domain-domain interactions in VWF, we pulled the 
shortest fragment D’D3 from VWF monomer using optical tweezers. The pulling 
velocity was 200 nm/s. Similar to other experiments, we brought the SpyTag-D’D3 
coupled bead in contact with another fixed, SpyCatcher-DNA handle coupled bead, for 
a constant dwell time (~2 s) at a low contact force (~5 pN), and then pulled away. Once 
a good tether was picked up, we set a minimum force (above zero) to prevent the 
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moving bead from contacting with the fixed one. Repeated approach-retract recycles 
were performed until the bonds dissociated. 
 Figure 4.1 shows typical approach-retract force-distance curves of pulling D’D3 
fragment, with a specific flat stage of DNA overstretching at ~65 pN. We observed 
some unfolding events during the retraction process (in Figure 4.2). The unfolding 
forces varied from ~10 pN to ~40 pN. The histogram of the unfolding extensions 
showed that the most probable unfolding distance is ~25 nm. However, there are few 
data points to make a solid conclusion. 
 
Figure 4.1 Single-molecule pulling results of D’D3 fragment. Typical approach-retract 
force-distance curves with DNA overstretching at ~65 pN. Few unfolding events were 
observed in the experiments. 
 
4.3.2 Pulling of D’D3A1 without FVIII 
Similar to Section 4.3.1, we performed single-molecule experiments using optical 
tweezers. The pulling velocity was 200 nm/s. The VWF fragment used was D’D3A1, 
with an extra A1 domain than before. Initially, we did not add any FVIII to the reaction 
buffer. Figure 4.2A shows typical approach-retract force-distance curves from the 
pulling of D’D3A1 fragments including a pattern of DNA overstretching. More 
unfolding events were observed, compared with that from the pulling of D’D3. Some 
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refolding events were also observed. By fitting the histogram of the unfolding extension 
to the Gaussian distribution, we obtained the most probable extension of 22.8 ± 1.9 nm 
(Figure 4.2B). After adding 5 nM FVIII to the Tris buffer, we observed much less 
unfolding events. 
 
Figure 4.2 Single-molecule pulling results of D’D3A1 fragment. (A) Typical approach-
retract force-distance curves from the pulling of D’D3A1 including a pattern of DNA 
overstretching. More unfolding events were observed, compared with that from the 
pulling of D’D3. Some refolding events were also observed. (B) The histogram of the 
unfolding extension. By fitting the histogram of the unfolding extension to the Gaussian 
distribution, we obtained the most probable extension of 22.8 ± 1.9 nm. After adding 5 
nM FVIII to the Tris buffer, we observed much less unfolding events. 
 
4.3.3 Pulling of D’D3A1A2 without FVIII 
In a further study, we performed single-molecule experiments on VWF D’D3A1A2 
fragment, in the absence of FVIII. Similar to Section 4.3.1, the optical tweezers were 
used to measure the force-induced conformational changes of D’D3A1A2. Three 
different pulling speeds, including 50 nm/s, 150 nm/s, and 200 nm/s, were used. We 
observed two unfolding events that occurred together in one retraction process (Figure 
4.3A), which was different from pulling D’D3 or D’D3A1. The two unfolding events 
contain one short unfolding (~15 nm) and one long unfolding (~40 nm). The histogram 
of the unfolding extension was shown in Figure 4.3B. By fitting the histogram data to 
a 2-peak Gaussian distribution, we obtained a short extension of 17.9 ± 0.6 nm, and a 
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longer extension of 39.4 ± 2.5 nm. The longer one could be the unfolding of the VWF 
A2 domain, while the shorter one might come from other parts of the fragment.  
 
Figure 4.3 Single-molecule pulling results of D’D3A1A2 fragment, without FVIII. (A) 
Typical approach-retract force-distance curves from the pulling of D’D3A1A2 without 
FVIII. We observed two unfolding events that occurred together in one retraction 
process. (B) The histogram of the unfolding extension. By fitting the histogram data to 
a 2-peak Gaussian distribution, we obtained a short extension of 17.9 ± 0.6 nm, and a 
longer extension of 39.4 ± 2.5 nm. The longer one could be the unfolding of the VWF 
A2 domain, while the shorter one might come from other parts of the fragment. 
 
4.3.4 Pulling of D’D3A1A2 with FVIII 
After pulling D’D3A1A2 without FVIII, we added 5 nM FVIII to the buffer, and 
saw the changes of force-extension curves (Figure 4.4A). It seemed that both the short 
and long unfolding events disappeared. Instead, an intermediate unfolding of ~20 nm 
appeared. By fitting the unfolding force histogram data to the Gaussian distribution 
(Figure 4.4B), we found the most likely unfolding force is 24.5 ± 0.4 nm. This change 
should be caused by the interaction between FVIII and D’D3A1A2, such that FVIII 
changed the structure of D’D3A1A2 after binding to it. 
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Figure 4.4 Single-molecule pulling results of D’D3A1A2 fragment, with FVIII. (A) 
Typical force-extension curves of pulling D’D3A1A2 with 5nM FVIII. It seemed that 
both the short and long unfolding events, seen when pulling D’D3A1A2 without FVIII 
disappeared. Instead, an intermediate unfolding of ~20 nm appeared. By fitting the 
unfolding force histogram data to the Gaussian distribution, we found the most likely 
unfolding force is 24.5 ± 0.4 nm. This change should be caused by the interaction 
between FVIII and D’D3A1A2, such that FVIII changed the structure of D’D3A1A2 
after binding to it. 
 
4.3.5 Interaction between FVIII and D’D3A1A2 Using AFM 
In this subsection, we used the home-built AFM to measure the dynamic force 
spectrum of the FVIII–D’D3A1A2 interaction, since the unbinding forces are too high 
for optical tweezers. FVIII-coated cantilever was brought to interact with D’D3A1A2, 
immobilized on the dish surface. The cantilever was controlled by the piezoelectric 
actuator to move back and forward at a constant speed. A dwell time of ~1 s to 5 s was 
set to control the interaction time for bond formation. Five different pulling speeds were 
performed to get five different force loading rates. Rupture forces at 5 different loading 
rates/pulling speeds were plotted as histograms. Each histogram was fitted to a 
Gaussian curve to obtain the most probable force. Error bar on force is the SEM of the 
force. The red solid line (Figure 4.5) is the least squares fit of the data to the Bell–Evans 
model [33]. The fitting results showed that, the intrinsic off-rate of the binding is k0 = 
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2.80 ± 1.03 s-1, and the barrier width between the naive state and the transition state is 
Δx‡ = 1.70 ± 0.18 Å. 
 
Figure 4.5 Dynamic force spectrum of D’D3A1A2–FVIII interaction. Five different 
pulling speeds were performed to get five different force loading rates. Rupture forces 
were plotted as histograms. Each histogram was fitted to a Gaussian curve to obtain the 
most probable force. Error bar on force is the SEM of the force. The red solid line is the 
least squares fit of the data to the Bell–Evans model [33]. The fitting results gave the 
intrinsic off-rate of the binding is k0 = 2.80 ± 1.03 s-1, and the barrier width between the 
naive state and the transition state is Δx‡ = 1.70 ± 0.18 Å. 
 
4.3.6 Pulling of VWF A2 Protein 
In previous sections, we inferred that, after FVIII bound to FVIII, it might interact 
with A1A2 domains and altered A2 unfolding, so that we observed an intermediate state 
when pulling FVIII from the D’D3A1A2 fragment. However, whether FVIII interacts 
with A2 directly remains questionable. To answer this, we designed the single-molecule 
pulling experiments in two approaches. In the first approach, we used the newly 
developed SpyTag system (Chapter 3), where A2 was fused with SpyTag and not 
purified. Laser optical tweezers measurement was very similar to that described in 
Section 3.2.3 on the non-purified integrin α4β7 supernatant. In the second approach, we 
coupled A2 domains with DNA handles through N- and C-terminal Cys tags. Two kinds 
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of carboxyl-polystyrene 2.0-μm beads (10 mg, Spherotech, Lake Forest, IL) were 
prepared. One kind of beads were the SA beads, described previously. The other kind 
of beads were coated with sheep anti-digoxigenin IgG (Roche) using a similar protocol, 
termed as anti-dig beads. Laser optical tweezers experiment was performed by pulling 
one anti-dig bead from the A2-handle, which was captured by one SA bead. In both 
approaches, we wanted to add FVIII after observing the typical unfolding of A2 
domains, and see whether it directly changed the unfolding pathway of A2 domains. 
 
Figure 4.6 Overlaid retract force-extension curves of pulling A2 using the SpyTag 
system. The supernatant of SpyTag-A2, fused with SpyTag and A2 protein, was used. 
Colored traces are the pulling curves of A2. A typical DNA overstretching was 
observed (~65 pN). An unfolding event occurred at ~10 pN, which is comparable with 
[53]. Besides, another unfolding event occurred at a higher force ~45 pN, which might 
indicate that there existed an intermediate state. The newly developed SpyTag system 
still performed well in this experiment. 
Figure 4.6 shows the overlaid force-extension curves (colored lines) of pulling A2 
using the developed SpyTag system (Chapter 3). In this system, the VWF A2 protein 
was fused to SpyTag, and was not purified. Without the existence of FVIII, a typical 
pattern of DNA overstretching was observed (~65 pN). An unfolding event occurred at 
~10 pN, which corresponded to the normal unfolding of the A2 domain reported in [53]. 
Besides, another unfolding event occurred at a higher force ~45 pN, which might 
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indicate that there existed an intermediate state from the pulling of SpyTag-A2 fusion 
protein. We can see that, the newly developed SpyTag system still performed well in 
this experiment. 
In the second pulling system, we also observed the regular unfolding of the A2 
domain with FVIII. Some preliminary results of its unfolding force and extension data 
are shown in Figure 4.7. The A2 protein, coupled with DNA handle, was immobilized 
by one SA bead, and one optical trap-controlled anti-dig bead was brought into contact 
with the SA bead and pulled away. The reaction buffer did not include FVIII. The 
unfolding extensions (~25 nm) and unfolding force (~10 pN) were comparable with 
published results [53]. When appropriate, the force-extension data would be fitted to 
the WLC model (Eq. (1.1)) to extract the contour length and the persistence of A2, and 
compared with published results. 
 
Figure 4.7 Single-molecule pulling results of A2 protein, without FVIII. The results 
were obtained by pulling A2 protein captured by one SA bead from one anti-dig bead, 
without the existence of FVIII. The unfolding extensions (~25 nm) and unfolding force 
(~10 pN) were comparable with published results [53]. When appropriate, the force-
extension data would be fitted to the WLC model to extract the contour length and the 
persistence of A2, and compared with published results. 
After observing the regular unfolding of the A2 protein, we added 5 nM of FVIII 
into the Tris buffer (150 mM NaCl, 10 mM Tris·HCl, pH 7.5), and repeated the pulling 
experiments. We did observe the unfolding of the A2 protein. However, at this moment, 
we did not have enough unfolding events to compare the biomechanical properties of 
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A2 with these measured in absence of FVIII. Figure 4.8 shows a typical pulling curve 
of A2 with FVIII. 
 
Figure 4.8 A typical retract curve of pulling A2, with FVIII. From the pulling of A2 
protein with the existence of 5 nM FVIII, we observed an unfolding event, but could 
not know whether it was altered due to the lack of more events. 
 
4.4 Discussion and Conclusion 
These results have shown that there are some differences in the force spectrum of 
pulling D’D3A1 or D’D3A1A2, in the absence or presence of 5 nM factor VIII. 
However, in order to clearly clarify the function of FVIII and the interaction between 
FVIII and D’D3A1 or D’D3A1A2, we need to obtain more unfolding events. We need 
to extract the characteristics of unfoldings in both pulling D’D3A1 and D’D3A1A2, 
and compare the later one with VWF A2 unfolding pathways. Furthermore, we may 
need to use D’D3 generated by mammal cells, instead of bacteria cells to repeat the 
single-molecule experiments.  
We expect to see that FVIII interacts with some sites either on VWF A1, A2, or 
somewhere between A1 and A2, to form a more stable complex. The new complex 
unfolds in a different way from A2, but with a longer lifetime. This will help to clarify 
the function of FVIII in platelet binding to membrane surfaces at the single molecular 
level. 
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4.5 Authorship Statement 
In this project, Xiaohui (Frank) Zhang designed the research. The Synthetic SpyTag 
with C-terminal Cysteine (AHIVMVDAYKPTKGGC) or N-terminal Cysteine 
(CGGAHIVMVDAYKPTK) used in the single-molecule experiments was purchased 
from Genscript (Piscataway, NJ).  The collaborator Dr. Mark Howarth at the University 
of Oxford provided the SpyCatcher. The collaborator Dr. X. Long Zheng at the 
University of Alabama at Birmingham provided the VWF fragments with SpyTag. We 
expressed the VWF A2 protein. I performed the optical tweezers experiments and 
analyzed the data.  
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Conclusion 
Single-molecule experiments have been performed to study the biological and 
mechanical properties of proteins and molecular interactions [1, 2, 133]. There are a 
variety of different single-molecule techniques, including atomic force microscopy 
(AFM) [4–8], optical tweezers [9–19], magnetic tweezers [20–27], and biomembrane 
force probes (BFP) [28–30]. High spatial resolution (nanometers), temporal resolution 
(microseconds), and force sensitivity (piconewtons) can be achieved by using the 
developed instruments, based on these single-molecule techniques. The single-
molecule experiments are carried out in the force-clamp mode, where a constant force 
is applied, or force-ramp mode, where the applied force increases linearly with the time, 
usually pulling at a constant speed. To quantify the biological properties of molecules, 
the molecule is treated as an elastic chain and the worm-like chain model [31, 32] is 
then applied. Furthermore, , the Bell–Evans model [33] and the Dudko model [34], both 
of which are derived from Kramers theory [35], can be applied to characterize the 
mechanical properties of proteins or bonds and to plot the free energy landscape. 
In my first dissertation project [58, 206], we used the mini-optical tweezers to 
perform single-molecule force experiments on the platelet mechanosensor glycoprotein 
(GP) Ib-IX complex. The mechanical shear force generated by blood flow in the 
vasculature is an important factor that mediates physiologic hemostasis and pathologic 
thrombosis. Elevated shear stress induces binding of the von Willebrand factor (VWF) 
to the GPIb-IX complex on the platelet surface and induces platelet activation. Both 
GPIb-IX and VWF are capable of sensing and reacting to tensile forces. Earlier studies 
by the Springer group [53] have identified the mechanosensor within VWF, the A2 
domain, which unfolds at a tensile force of 10–20 pN, and is cleaved by plasma enzyme 
ADAMTS13. Although GPIb-IX complex has long been recognized as the platelet 
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mechanosensor, how it senses the blood flow through its binding to VWF and converts 
this mechanical information into a protein-mediated signal that can be recognized and 
propagated has remained elusive. We successfully identified a juxtamembrane 
mechanosensory domain (MSD) in GPIb-IX, and further proposed a model of GPIb-IX 
mechanosensing (and further named it “the trigger model”). In this model, the force-
induced unfolding of MSD is the step by which GPIb-IX converts a mechanical signal 
into a change in protein conformation, a type of signal that could be recognized and 
transduced further. This has significant implications for the pathogenesis and treatment 
of related blood diseases. 
Though these single-molecule techniques and instruments have allowed for the 
direct pulling of single molecules, a well-designed system for holding the two ends of 
a molecule is necessary. Most of the traditional linkage systems offer low mechanical 
stability and strength. The disulfide coupling method is mechanically strong, but 
requires the reduction reaction to the protein sample, which is not practical for 
complexed proteins with an abundance of inner disulfide bonds, such as the VWF. 
Therefore, we aimed to develop a specific and strong covalent coupling method for 
single-molecule experiments. 
In my second project, the novel SpyTag linkage has been developed and 
demonstrated to have high mechanical stability and strength. The covalent bonds of the 
SpyTag/SpyCatcher are very stable to the point where they can be held at high forces 
for as long as 1.4 h. Since there is not much difference between the lifetimes of the C-
SpyTag/SpyCatcher and the N-SpyTag/SpyCatcher, we can add SpyTag to either of its 
termini without sacrificing the stability of the covalent bonds. This also makes the 
single molecular experiments simpler. The first application of this SpyTag system was 
on the single maltose-binding protein (MBP) pulling experiments, which showed its 
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unprecedented advantage of experimental efficiency. From the pulling of a single tether 
at a pulling speed of 500 nm/s, we obtained 65 good force-extension curves. The stable 
SpyTag system allowed us to perform single-molecule experiments in such an efficient 
way that a good histogram of unfolding forces/extension can be obtained using one 
single tether at a time. Fitting the unfolding force-extension data to the worm-like chain 
(WLC) model [31] yielded a comparable contour length and a persistence length with 
previous reports [200]. Moreover, the force extension curves indicated an intermediate 
state of MBP unfolding, at a lower force ~25 pN. 
The new SpyTag system simplifies the single-molecule experiments by eliminating 
the sample purification step, as well as providing a new approach to investigate 
complexed proteins, such as the α4β7 integrin. Moreover, the novel system eliminates 
the protein reduction procedure, which makes it promising for measuring protein’s 
domain-domain interactions, such as the von Willebrand factor (VWF). This kind of 
protein has disulfide bonds inside its internal structure, so the reduction reaction, 
required by some traditional single-molecule force spectroscopy methods, destroys the 
disulfide bonds and thus alter the structure and properties of the protein. 
Finally, in my third project, we aimed to investigate the domain-domain interactions 
within VWF, as well as the function of clotting factor VIII (FVIII) in VWF 
folding/unfolding, using the novel SpyTag system. There exists some difference in the 
force spectrum of pulling D’D3A1 or D’D3A1A2, in the absence or presence of the 5 
nM factor VIII. However, more unfolding events are required to reveal the function of 
FVIII and the interaction between FVIII and D’D3A1 or D’D3A1A2. The function of 
FVIII on VWF A2 unfolding pathways should also be studied separately to further 
confirm FVIII’s function.  
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In summary, my dissertation studies have provided a deeper understanding of the 
structure and function of GPIb-IX and VWF, and have significant implications for the 
pathogenesis and treatment of related blood diseases. In addition, the technical 
platforms developed, including the usage of SpyTag in optical tweezers experiments, 
is not limited to the chosen model system, and can potentially be applied to a broad 
range of protein structural and functional studies. 
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Appendix 
Protocol of Coating the Polystyrene Beads 
1. Take 100 μL 2.04-μm Carboxyl-polystyrene beads (Bangs Laboratories, Inc., 
Catalog# PC05N), and add to 1.5 mL Eppendorf tube. 
2. Centrifuge at 720 × G for 5 min, and remove the supernatant. 
3. Dissolve the pellet with 0.4 mL PolyLink Coupling Buffer (Polysciences. Inc, 
Catalog# 2435A). 
4. Repeat the steps 2–3–2 twice. 
5. Add 0.2 mL PolyLink Coupling Buffer, same as before, to dissolve the pellet. 
6. Freshly prepare 200 mg/mL EDAC solution by mixing 7 mg PolyLink EDAC 
(Polysciences, Inc., Catlaog# 2435C) with 35 μL PolyLink Coupling Buffer, same 
as before. 
7. Take 10 μL EDAC solution prepared in step 6, and mix it with the beads in step 5. 
8. Vortex for 10 min at room temperature. 
9. Add the protein (streptavidin, antibody, or anti-digoxigenin) at a concentration of 
about 1 mg/mL. 
10. Seal the tube with Parafilm M® film, and shake for 1 hour at room temperature. 
11. Centrifuge at 720 × G for 5 min, and remove the supernatant. 
12. Wash 5 times with 0.4 mL PBS (with 0.02% Tween 20) for each time. 
13. Add 0.2 mL PBS (with 0.02% Tween 20) and 0.2 mL PBS (with 2 mM Sodium 
azide) to the tube. 
14. Store at 4 °C for future use. 
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